Document_And_Entity_Informatio
Document And Entity Information (USD $) | 12 Months Ended | ||
Jun. 30, 2014 | Sep. 08, 2014 | Dec. 31, 2013 | |
Document and Entity Information [Abstract] | ' | ' | ' |
Entity Registrant Name | 'BION ENVIRONMENTAL TECHNOLOGIES INC | ' | ' |
Document Type | '10-K | ' | ' |
Current Fiscal Year End Date | '--06-30 | ' | ' |
Entity Common Stock, Shares Outstanding | ' | 19,082,759 | ' |
Entity Public Float | ' | ' | $7,000,000 |
Amendment Flag | 'false | ' | ' |
Entity Central Index Key | '0000875729 | ' | ' |
Entity Current Reporting Status | 'Yes | ' | ' |
Entity Voluntary Filers | 'No | ' | ' |
Entity Filer Category | 'Smaller Reporting Company | ' | ' |
Entity Well-known Seasoned Issuer | 'No | ' | ' |
Document Period End Date | 30-Jun-14 | ' | ' |
Document Fiscal Year Focus | '2014 | ' | ' |
Document Fiscal Period Focus | 'FY | ' | ' |
Consolidated_Balance_Sheets
Consolidated Balance Sheets (USD $) | Jun. 30, 2014 | Jun. 30, 2013 |
Current assets: | ' | ' |
Cash | $186,148 | $44,666 |
Restricted cash | ' | 57,315 |
Prepaid expenses | 17,006 | 44,812 |
Subscription receivable (Note 8) | 30,000 | 25,000 |
Deposits and other receivables | 7,108 | 6,108 |
Total current assets | 240,262 | 177,901 |
Property and equipment, net (Note 3) | 4,351,153 | 7,331,020 |
Total assets | 4,591,415 | 7,508,921 |
Current liabilities: | ' | ' |
Accounts payable and accrued expenses | 1,434,381 | 1,010,528 |
Deferred rent | ' | 10,929 |
Loans payable - affiliates (Note 4) | 382,458 | 276,618 |
Deferred compensation (Note 5) | 716,734 | 520,583 |
Convertible notes payable - affiliates (Note 7) | 1,736,502 | ' |
Loan payable (Note 6) | 7,754,000 | 7,754,000 |
Total current liabilities | 12,024,075 | 9,572,658 |
Convertible notes payable - affiliates (Note 7) | ' | 1,316,478 |
Total liabilities | 12,024,075 | 10,889,136 |
Deficit: | ' | ' |
Common stock, no par value, 100,000,000 shares authorized, 19,576,619 and 17,673,983 shares issued, respectively; 18,872,310 and 16,969,674 shares outstanding, respectively | 0 | 0 |
Additional paid-in capital | 98,537,032 | 96,829,488 |
Accumulated deficit | -106,067,869 | -100,308,856 |
Total Bion's stockholders' deficit | -7,530,837 | -3,479,368 |
Noncontrolling interest | 74,777 | 77,753 |
Total deficit | -7,456,060 | -3,401,615 |
Total liabilities and deficit | 4,591,415 | 7,508,921 |
Series B Preferred Stock [Member] | ' | ' |
Current liabilities: | ' | ' |
Preferred stock | 23,400 | 21,400 |
Series A Preferred Stock [Member] | ' | ' |
Current liabilities: | ' | ' |
Preferred stock | 0 | 0 |
Series C Preferred Stock [Member] | ' | ' |
Current liabilities: | ' | ' |
Preferred stock | $0 | $0 |
Consolidated_Balance_Sheets_Pa
Consolidated Balance Sheets (Parentheticals) (USD $) | Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2014 | Jun. 30, 2013 |
Series B Preferred Stock [Member] | Series B Preferred Stock [Member] | Series A Preferred Stock [Member] | Series A Preferred Stock [Member] | Series C Preferred Stock [Member] | Series C Preferred Stock [Member] | |||
Par value (in Dollars per share) | ' | ' | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 |
Shares authorized | ' | ' | 50,000 | 50,000 | 10,000 | 10,000 | 60,000 | 60,000 |
Shares issued | ' | ' | 200 | 200 | 0 | 0 | 0 | 0 |
Shares outstanding | ' | ' | 200 | 200 | 0 | 0 | 0 | 0 |
Liquidation preference (in Dollars per share) | ' | ' | $26,000 | $24,000 | ' | ' | ' | ' |
Common stock, shares authorized | 100,000,000 | 100,000,000 | ' | ' | ' | ' | ' | ' |
Common stock, shares issued | 19,576,619 | 17,673,983 | ' | ' | ' | ' | ' | ' |
Common stock, shares outstanding | 18,872,310 | 16,969,674 | ' | ' | ' | ' | ' | ' |
Common stock, par value (in Dollars per share) | $0 | $0 | ' | ' | ' | ' | ' | ' |
Consolidated_Statements_of_Ope
Consolidated Statements of Operations (USD $) | 12 Months Ended | |
Jun. 30, 2014 | Jun. 30, 2013 | |
Revenue | $5,931 | $11,862 |
Operating expenses: | ' | ' |
General and administrative (including stock-based compensation (Note 8)) | 2,269,045 | 6,874,573 |
Depreciation | 978,798 | 905,871 |
Impairment loss on property and equipment (Note 3) | 2,000,000 | ' |
Research and development (including stock-based compensation (Note 8)) | 134,862 | 191,709 |
Total operating expenses | 5,382,705 | 7,972,153 |
Loss from operations | -5,376,774 | -7,960,291 |
Other expense: | ' | ' |
Interest expense | 403,410 | 289,604 |
Gain on extinguishment of liabilities (Note 9) | -20,113 | ' |
Other expense | 1,918 | ' |
385,215 | 289,604 | |
Net loss | -5,761,989 | -8,249,895 |
Net loss attributable to the noncontrolling interest | 2,976 | 6,134 |
Net loss attributable to Bion | -5,759,013 | -8,243,761 |
Dividends on preferred stock | -2,000 | -4,417 |
Net loss applicable to Bion's common stockholders | ($5,761,013) | ($8,248,178) |
Net loss applicable to Bion's common stockholders per basic and diluted common share (in Dollars per share) | ($0.31) | ($0.48) |
Weighted-average number of common shares outstanding: | ' | ' |
Basic and diluted (in Shares) | 18,636,364 | 17,315,436 |
Consolidated_Statements_Of_Cha
Consolidated Statements Of Changes In Equity (Deficit) (USD $) | Series B Preferred Stock [Member] | Series B Preferred Stock [Member] | Series C Preferred Stock [Member] | Series C Preferred Stock [Member] | Series C Preferred Stock [Member] | Series C Preferred Stock [Member] | Sale of Units [Member] | Sale of Units [Member] | Sale of Units [Member] | Stock Issued to Satisfy Accounts Payable [Member] | Stock Issued to Satisfy Accounts Payable [Member] | Stock Issued to Satisfy Accounts Payable [Member] | Series C Preferred Stock [Member] | Common Stock [Member] | Additional Paid-in Capital [Member] | Retained Earnings [Member] | Noncontrolling Interest [Member] | Total |
Additional Paid-in Capital [Member] | USD ($) | USD ($) | Common Stock [Member] | Additional Paid-in Capital [Member] | USD ($) | Common Stock [Member] | Additional Paid-in Capital [Member] | USD ($) | Common Stock [Member] | Additional Paid-in Capital [Member] | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||
USD ($) | USD ($) | USD ($) | USD ($) | |||||||||||||||
Balance, amount at Jun. 30, 2012 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $29,050 | ' | $91,177,978 | ($92,065,095) | $83,887 | ($774,180) |
Balance, shares (in Shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 17,673,983 | ' | ' | ' | ' |
Vesting of options for services | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 455,080 | ' | ' | 455,080 |
Issuance of common stock for services, amount | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,269,390 | ' | ' | 1,269,390 |
Issuance of common stock for services, shares (in Shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 124,157 | ' | ' | ' | ' |
Modification of options | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 611,700 | ' | ' | 611,700 |
Issuance of warrants for services and interest | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 36,879 | ' | ' | 36,879 |
Modification of warrants | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,893,325 | ' | ' | 1,893,325 |
Issuance of stock, other, amount | ' | ' | ' | ' | ' | ' | ' | 1,060,499 | 1,060,499 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Issuance of stock, other, shares (in Shares) | ' | ' | ' | ' | ' | ' | 508,056 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Sale of common stock, amount | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 292,375 | ' | ' | 292,375 |
Sale of common stock, shares (in Shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 216,000 | ' | ' | ' | ' |
Dividend on preferred stock | -2,417 | -2,417 | 2,000 | ' | -2,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | -2,000 |
Conversion, amount | ' | ' | -31,050 | ' | 36,679 | 5,629 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Conversion, shares (in Shares) | ' | ' | -300 | 11,667 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net loss | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | -8,243,761 | -6,134 | -8,249,895 |
Balance, amount at Jun. 30, 2013 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 96,829,488 | -100,308,856 | 77,753 | -3,401,615 |
Balance, shares (in Shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 19,576,619 | ' | ' | ' | ' |
Vesting of options for services | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | -204,257 | ' | ' | -204,257 |
Issuance of common stock for services, amount | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 307,102 | ' | ' | 307,102 |
Issuance of common stock for services, shares (in Shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 360,066 | ' | ' | ' | ' |
Modification of options | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 307,638 | ' | ' | 307,638 |
Issuance of warrants for services and interest | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 14,046 | ' | ' | 14,046 |
Issuance of stock, other, amount | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 19,940 | 19,940 | ' | ' | ' | ' | ' | ' |
Issuance of stock, other, shares (in Shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | 13,369 | ' | ' | ' | ' | ' | ' | ' | ' |
Sale of common stock, amount | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 967,575 | ' | ' | 967,575 |
Sale of common stock, shares (in Shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,279,201 | ' | ' | ' | ' |
Dividend on preferred stock | -2,000 | -2,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Conversion, amount | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 297,500 | ' | ' | 297,500 |
Conversion, shares (in Shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 250,000 | ' | ' | ' | 250,000 |
Net loss | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | -5,759,013 | -2,976 | -5,761,989 |
Balance, amount at Jun. 30, 2014 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $98,537,032 | ($106,067,869) | $74,777 | ($7,456,060) |
Consolidated_Statements_Of_Cas
Consolidated Statements Of Cash Flows (USD $) | 12 Months Ended | |
Jun. 30, 2014 | Jun. 30, 2013 | |
CASH FLOWS FROM OPERATING ACTIVITIES | ' | ' |
Net loss | ($5,761,989) | ($8,249,895) |
Adjustments to reconcile net loss to net cash used in operating activities: | ' | ' |
Loss on disposal of property and equipment | 1,919 | ' |
Depreciation expense | 978,798 | 905,871 |
Impairment loss on property and equipment | 2,000,000 | ' |
Accrued interest on deferred compensation and other | 360,326 | 223,292 |
Stock-based compensation | 397,780 | 4,266,374 |
Decrease (increase) in prepaid expenses | 27,806 | -2,105 |
(Increase) decrease in deposits and other receivables | -1,000 | 850 |
Increase in accounts payable and accrued expenses | 287,280 | 209,149 |
Increase in deferred compensation | 728,400 | 777,550 |
Decrease in deferred rent | -10,929 | -17,063 |
Net cash used in operating activities | -991,609 | -1,885,977 |
CASH FLOWS FROM INVESTING ACTIVITIES | ' | ' |
Release of restricted cash | 57,315 | ' |
Purchase of property and equipment | -850 | -64,189 |
Net cash provided (used) in investing activities | 56,465 | -64,189 |
CASH FLOWS FROM FINANCING ACTIVITIES | ' | ' |
Decrease in subscription receivable | 25,000 | ' |
Proceeds from the sale of units | ' | 1,060,499 |
Proceeds from sale of common stock | 944,400 | 270,000 |
Proceeds from loans payable b affiliates | 185,149 | 295,000 |
Share issuance costs | -6,825 | ' |
Net cash provided by financing activities | 1,076,626 | 1,594,840 |
Net increase (decrease) in cash | 141,482 | -355,326 |
Cash at beginning of period | 44,666 | 399,992 |
Cash at end of period | 186,148 | 44,666 |
Supplemental disclosure of cash flow information: | ' | ' |
Cash paid for interest, including nil and $15,793 of capitalized interest | 1,098 | 98,747 |
Non-cash investing and financing transactions: | ' | ' |
Issuance of common stock to satisfy deferred compensation | 26,749 | ' |
Subscription receivable | 30,000 | 25,000 |
Payment of loans payable b affiliates | -71,098 | ' |
Series B Preferred Stock [Member] | ' | ' |
CASH FLOWS FROM FINANCING ACTIVITIES | ' | ' |
Payment of Series B preferred dividends | ' | -2,917 |
Non-cash investing and financing transactions: | ' | ' |
Preferred stock dividends declared | 2,000 | 2,417 |
Redemption of Series B preferred shares | ' | -25,000 |
Series C Preferred Stock [Member] | ' | ' |
CASH FLOWS FROM FINANCING ACTIVITIES | ' | ' |
Share issuance costs | ' | -2,742 |
Non-cash investing and financing transactions: | ' | ' |
Preferred stock dividends declared | ' | 2,000 |
Conversion of Series C preferred to common stock | ' | 36,796 |
Stock Issued to Satisfy Accounts Payable [Member] | ' | ' |
Non-cash investing and financing transactions: | ' | ' |
Issuance of common stock to satisfy payables | 19,940 | ' |
Stock Issued to Satisfy Convertible Notes Payable [Member] | ' | ' |
Non-cash investing and financing transactions: | ' | ' |
Issuance of common stock to satisfy payables | $297,500 | ' |
Consolidated_Statements_Of_Cas1
Consolidated Statements Of Cash Flows (Parentheticals) (USD $) | 12 Months Ended | |
Jun. 30, 2014 | Jun. 30, 2013 | |
Capitalized interest | $0 | $15,793 |
Note_1_Organization_Nature_of_
Note 1 - Organization, Nature of Business, Going Concern and Management's Plans: | 12 Months Ended | |
Jun. 30, 2014 | ||
Disclosure Text Block [Abstract] | ' | |
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] | ' | |
1 | ORGANIZATION, NATURE OF BUSINESS, GOING CONCERN AND MANAGEMENT’S PLANS: | |
Organization and nature of business: | ||
Bion Environmental Technologies, Inc. (“Bion” or “We” or the "Company") was incorporated in 1987 in the State of Colorado and has developed and continues to develop patented and proprietary technology and business models that provide comprehensive environmental solutions to a significant source of pollution in United States agriculture, large scale livestock facilities known as Confined Animal Feeding Operations ("CAFO's"). Bion's technologies (and applications related thereto) produce substantial reductions of nutrient releases (primarily nitrogen and phosphorus) to both water and air (including ammonia, which is subsequently re-deposited to the ground) from livestock waste streams based upon our operations and research to date (and third party peer review thereof). Because Bion's technologies (and related applications) reduce the harmful releases and emissions from a CAFO on which it is utilized, the CAFO can potentially increase its herd concentration (thereby utilizing less land per animal) while lowering or maintaining its level of nutrient releases and atmospheric emissions. Bion provides comprehensive and cost-effective treatment of livestock waste onsite, while it is still concentrated and before it contaminates air, soil, groundwater aquifers and/or downstream waters. | ||
From 2003 through early 2008, the Company primarily focused on completing re-development of its technology platform and business model. As such, during that period Bion elected not to pursue near-term business opportunities such as retrofitting existing CAFO's with waste management solutions, because management believed such efforts would have diverted scarce management and financial resources and negatively impacted Bion’s ability to complete: 1) re-development of technologies for environmentally sound treatment of CAFO waste streams and 2) development of an integrated technology platform in support of large-scale sustainable Integrated Projects (defined below) including renewable energy production. During the 2014 fiscal year the Company increased its research and development activities with focus on creating variations of its technology platform that create additional flexibility, increase recovery of nutrient by-products and to review potential “add-ons” and applications for use in different regulatory environments. These research and development activities will continue through the 2015 fiscal year. | ||
Bion is now actively pursuing business opportunities in three broad areas 1) installation of Bion systems to retrofit and environmentally remediate existing CAFO’s to reduce nutrient (primarily nitrogen and phosphorus) releases, gaseous emissions (ammonia, greenhouse gases, volatile organic compounds, etc.), and pathogens, hormones and other compounds in order to clean the air and water in the surrounding areas (as described below) to ensure compliance with existing (and future) regulations and to permit herd expansion; 2) development of Integrated Projects opportunities within the United States and internationally; and 3) licensing and/or joint venturing of Bion’s technology and applications outside North America. The opportunities described at 1) and 2) above (and below) each require substantial political (federal, state and local) efforts on the part of the Company and a substantial part of Bion’s efforts are focused on such political matters. | ||
Management believes that Bion's technology platform (including utilization of various third party technologies to supplement the Company’s proprietary technologies) allows the integration of large-scale CAFO's and their end-product users, renewable energy production from the CAFO waste stream, on site utilization of the renewable energy generated and biofuel/ethanol production in an environmentally and economically sustainable manner while reducing the aggregate capital expense and operating costs for the entire integrated complex ("Integrated Projects" or "Projects"). In the context of Integrated Projects, Bion's waste treatment process, in addition to mitigating polluting releases, enables generation of renewable energy from cellulosic portions of the CAFO waste stream, which renewable energy can be utilized by integrated facilities including ethanol plants, CAFO end-product processors (including cheese, ice cream and/or bottling plants in the case of dairy CAFO’s and/or slaughter and/or processing facilities in the context of beef CAFO’s) and/or other users as a fossil fuel replacement. The nutrients (primarily nitrogen and phosphorus) can be harvested from the solids and liquid streams recovered from the livestock waste stream and can be utilized as either high value fertilizer and/or the basis for high protein animal feed and the nutrient rich effluent can potentially be utilized in integrated hydroponic agriculture and/or field applied as fertilizer. Bion believes that its Integrated Projects will produce high quality, traceable animal protein at a lower cost than current industry practices while also maintaining a far lower net environmental footprint per unit of protein produced due to water recycling (possible due to the removal of nutrients, etc. from the water by Bion’s technology applications), production of renewable energy from the waste stream (reducing the use of fossil fuels), and multiple levels of economies of scale, co-location and integration savings in transportation and other logistics. Some projects may involve only partial integration which will limit the benefits described herein. | ||
Bion is presently involved in the very early development and pre-development activities related to its initial Integrated Project(s) in Pennsylvania. The Company is also involved in pre-development evaluations and discussions regarding opportunities for Integrated Projects in the Northeast, Midwest, and the North Central United States (dairy and/or beef). While all such discussions are still in preliminary stages, multiple meetings and discussions are ongoing with local and state level Pennsylvania officials related to the development of a Bion Integrated Project involving a major international livestock entity with existing operations in Pennsylvania. Additionally, the Company is involved in early stage discussions regarding development of Integrated Projects to meet specific needs of certain international markets (and regarding licensing our technology for use in overseas locations). | ||
Additionally, Bion has commenced discussions that may lead to installation of Bion systems on existing and/or new dairies, beef facilities and swine farms in the Midwest and/or North Central states. The most advanced discussions currently involve an initiative by Bion in Wisconsin. | ||
On September 27, 2008, the Company executed an agreement with Kreider Farms (and its affiliated entities) (collectively "Kreider") to design, construct and operate (through its wholly-owned subsidiaries, Bion Services Group, Inc. (“Bion Services”) and Bion PA-1 LLC (“PA-1”) a Bion system to treat the waste of 1,200 milking dairy cows (milkers, dry cows and heifers) at the Kreider Dairy, located in Manheim, Pennsylvania. In addition, the agreement (as amended and supplemented) provides for a second phase which will treat the wastes from the rest of Kreider’s herd and includes renewable energy production from the cellulosic solid wastes from the Phase 1 system (referred to as “Kreider 1”) together with the waste stream from Kreider’s poultry facilities for use at the facilities and/or for market sales. The Kreider projects are owned and operated by Bion through subsidiaries, in which Kreider has the option to purchase a noncontrolling interest. To complete these projects, substantial capital (equity and/or debt) has been and will continue to be expended. Additional funds will be required for continuing operations of Kreider 1 until sufficient revenues can be generated, of which there is no assurance. The Company anticipates that it will earn revenue primarily from the sale of nutrient reduction (and/or other) environmental credits related to Kreider 1 and the Kreider Phase 2 poultry waste treatment system (not yet constructed), and secondarily through sales of renewable energy generated by the Kreider Phase 2 system. To date the market for long-term nutrient reduction credits in Pennsylvania has been very slow to develop and the Company’s activities have been negatively affected by the lack of such development. A significant portion of Bion’s research and development activities is currently taking place at the Kreider 1 facility. | ||
The Company’s subsidiary PA-1 financed Kreider 1 through a $7.8 million loan (“Pennvest Loan”) from Pennsylvania Infrastructure Investment Authority (“Pennvest”) secured by Kreider 1 (and its revenue streams, if any) plus advances from the Company. Initial construction-related activities of Kreider 1 commenced in October 2010 and construction was completed and a period of system ‘operation shakedown’ commenced in May 2011. Kreider 1 reached full, stabilized operation by the end of the 2012 fiscal year. During 2011 the Pennsylvania Department of Environmental Protection (“PADEP”) re-certified the nutrient credits for this project. The economics (potential revenues and profitability) of Kreider 1 are based largely on the long-term sale of nutrient reduction credits (nitrogen and/or phosphorus) to meet the requirements of the Chesapeake Bay environmental clean-up. The PADEP issued final permits for Kreider 1 (including the credit verification plan) on August 1, 2012 on which date the Company deemed that Kreider 1 was ‘placed in service’. As a result, PA-1 has commenced generating nutrient reduction credits for potential sale while continuing to utilize the system to test improvements and add-ons. Operating results at Kreider 1 have documented the efficacy of Bion’s nutrient reduction technology and vetted potential ‘add-ons’ and modifications for use in future installations. During August 2012 the Company provided Pennvest (and the PADEP) with data demonstrating that Kreider 1 met the ‘technology guarantee’ standards which were incorporated in the Pennvest financing documents and, as a result, the Pennvest Loan is now solely an obligation of PA-1. To date liquidity in the Pennsylvania nutrient credit market has been slow to develop significant breadth and depth and limited liquidity has negatively impacted Bion’s business plans and has prevented Bion from monetizing the nutrient reduction credits created by PA-1’s existing Kreider 1 project and Bion’s other proposed projects. These challenges and difficulties have prevented PA-1 from generating any material revenues from the Kreider 1 project to date (operating expenses have been funded by loans from Bion) and raise significant questions as to when PA-1 will be able to generate such revenues from the Kreider 1 system. PA-1 has engaged in on-and-off negotiations with Pennvest related to forbearance, re-structuring and other matters related to the Kreider 1 project and its obligations pursuant to the Pennvest Loan. In the context of such negotiations, PA-1 elected not to make interest payments to Pennvest on the Pennvest Loan since January 2013. Additionally, the Company has not made any principal payments, which were to begin in fiscal 2013, and, therefore, the Company has classified the Pennvest Loan as a current liability as of June 30, 2014. Due to the slow development of the nutrient reduction credit market, the Company determined that the carrying amount of the property and equipment related to the Kreider 1 project exceeded its estimated future undiscounted cash flows based on certain assumptions regarding timing, level and probability of revenues from sales of nutrient reduction credits and, therefore, recorded a $2,000,000 impairment of the Kreider 1 assets which reduced the value of the Kreider 1 System to $4,349,482 as of June 30, 2014 (Note 3). Additional impairments may result if the nutrient credit market does not develop in the near term. | ||
On September 25, 2014 Pennvest exercised its right to declare the Pennvest Loan in default and has accelerated the Pennvest Loan and has demanded that PA-1 pay $8,137,117 (principal, interest plus late charges) on or before October 24, 2014. The Company anticipates that discussions and negotiations will take place between PA-1 and Pennvest concerning this matter of the next 30 days. It is not possible at this date to predict the outcome of such negotiations but the Company believes that an interim, short-term agreement will be reached that will allow PA-1 and Pennvest a further period of time for further negotiations and evaluation of possible long term resolutions. Subject to the results of the negotiations with Pennvest and pending development of a more robust market for nutrient reductions in Pennsylvania, PA-1 and Bion anticipate that it will be necessary for the Company to evaluate various options with regard to Kreider 1 over the next 30-180 days. | ||
During August 2012 the Company provided Pennvest (and the PADEP) with data demonstrating that the Kreider 1 system met the ‘technology guaranty’ standards which were incorporated in the Pennvest financing documents and, as a result, the Pennvest Loan is now solely an obligation of PA-1. | ||
Development work and technology evaluation, including amended credit certification and negotiations with potential joint venture partners, continues related to the details of the second phase of the Kreider project. Assuming there are positive developments related to the market for nutrient reduction in Pennsylvania, the Company intends to pursue development, design and construction of the Kreider 2 poultry waste/renewable energy project with a goal of achieving operational status during 2015. However, as discussed above, this project faces challenges related to the current limits of the existing nutrient reduction market and funding of technology-based, verifiable agricultural nutrient reductions. | ||
The limited development of the nutrient reduction market in Pennsylvania has led Bion to redeploy some of its limited resources from its efforts in Pennsylvania to its initiatives in the Great Lakes and Midwest states with current efforts being most advanced in Wisconsin which passed legislation (signed by its governor on April 23, 2014) that provides a policy and regulatory framework to reduce nutrient compliance costs through a collaborative effort by public and private sectors. The Company is actively involved in discussions with various stakeholders in Wisconsin including state and local government officials and agencies, wastewater authorities and agricultural industry entities. | ||
A significant portion of Bion’s activities concern efforts with private and public stakeholders (at local and state level) in Pennsylvania (and other Chesapeake Bay states) and in Wisconsin and at the federal level (the Environmental Protection Agency (“EPA”) (and other executive departments) and Congress) to establish appropriate public policies which will create regulations and funding mechanisms that foster installation of the low cost environmental solutions that Bion (and others) can provide through clean-up of agricultural waste streams. | ||
Going concern and management’s plans: | ||
The consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company has not generated significant revenues and has incurred net losses (including significant non-cash expenses) of approximately $5,762,000 and $8,250,000 during the years ended June 30, 2014 and 2013, respectively. At June 30, 2014, the Company has a working capital deficit and a stockholders’ deficit of approximately $11,784,000 and $7,531,000, respectively. These factors raise substantial doubt about the Company's ability to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments relating to the recoverability or classification of assets or the amounts and classification of liabilities that may result should the Company be unable to continue as a going concern. The following paragraphs describe management’s plans with regard to these conditions. | ||
The Company continues to explore sources of additional financing to satisfy its current operating requirements as it is not currently generating any significant revenues. | ||
During the years ended June 30, 2014 and 2013, the Company received total proceeds of $944,400 and $1,330,499, respectively, from the sale of its equity securities. Proceeds during the 2014 and 2013 fiscal years have been lower than in earlier years and accordingly has negatively impacted the Company’s business development efforts. | ||
During the year ended June 30, 2014, the Company sold 400,000 shares of the Company’s restricted common stock at $1.25 per share for proceeds of $500,000. During the year ended June 30, 2014, the Company also sold 592,534 shares of the Company’s restricted common stock at $0.75 per share for gross proceeds of $474,400, with net proceeds of $467,575 (including subscriptions receivable of $30,000 for 40,000 shares at June 30, 2014, received in July 2014). In addition, the Company issued 266,667 shares of the Company’s restricted common stock resulting from the terms in the subscription agreements related to the sale of the 400,000 shares, that required additional shares be issued if the Company sold stock at a price lower than $1.25 per share. | ||
During the year ended June 30, 2014 the Company entered into promissory note agreements with two affiliates of the Company whereby the affiliates have agreed to lend up to $75,000 each for working capital needs. As of June 30, 2014, the Company has borrowed $135,000 under these notes. | ||
During fiscal years 2014 and 2013, the Company experienced greater difficulty in raising equity funding than in the prior years. As a result, the Company faced, and continues to face, significant cash flow management challenges due to working capital constraints. To partially mitigate these working capital constraints, the Company’s core senior management and several key employees and consultants have been deferring (and continue to defer) all or part of their cash compensation and/or are accepting compensation in the form of securities of the Company (Notes 5 and 7) and members of the Company’s senior management have made loans to the Company (Note 4). Additionally, the Company has made reductions in its personnel during the year ended June 30, 2014. The constraint on available resources has had, and continues to have, negative effects on the pace and scope of the Company’s efforts to develop its business. The Company has had to delay payment of trade obligations and has had to economize in many ways that have potentially negative consequences. The Company’s accounts payable have increased materially in fiscal years 2013 and 2014. If the Company does not have greater success in its efforts to raise needed funds during fiscal 2015 (and subsequent periods), management will need to consider deeper cuts (including additional personnel cuts) and curtailment of operations (including possibly Kreider 1 operations). | ||
The Company will need to obtain additional capital to fund its operations and technology development, to satisfy existing creditors, to develop Integrated Projects and CAFO waste remediation systems (including the Kreider 2 facility) and to continue to operate the Kreider 1 facility. The Company anticipates that it will seek to raise from $2,500,000 to $50,000,000 or more (debt and equity) during the next twelve months. However, as discussed above, there is no assurance, especially in light of the difficulties the Company has experienced in recent periods and the extremely unsettled capital markets that presently exist (especially for small companies), that the Company will be able to obtain the funds that it needs to stay in business, complete its technology development or to successfully develop its business and projects. | ||
There is no realistic likelihood that funds required during the next twelve months or in the periods immediately thereafter for the Company’s basic operations and/or proposed projects will be generated from operations. Therefore, the Company will need to raise sufficient funds from external sources such as debt or equity financings or other potential sources. The lack of sufficient additional capital resulting from the inability to generate cash flow from operations and/or to raise capital from external sources would force the Company to substantially curtail or cease operations and would, therefore, have a material adverse effect on its business. Further, there can be no assurance that any such required funds, if available, will be available on attractive terms or that they will not have a significantly dilutive effect on the Company's existing shareholders. All of these factors have been exacerbated by the extremely unsettled credit and capital markets presently existing for small companies like Bion. |
Note_2_Significant_Accounting_
Note 2 - Significant Accounting Policies | 12 Months Ended | ||||||||
Jun. 30, 2014 | |||||||||
Accounting Policies [Abstract] | ' | ||||||||
Significant Accounting Policies [Text Block] | ' | ||||||||
2 | SIGNIFICANT ACCOUNTING POLICIES | ||||||||
Principles of consolidation: | |||||||||
The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Bion Integrated Projects Group, Inc. (“Projects Group”), Bion Technologies, Inc., BionSoil, Inc., Bion Services, PA-1, and Bion PA 2 LLC; and its 58.9% owned subsidiary, Centerpoint Corporation (“Centerpoint”). All significant intercompany accounts and transactions have been eliminated in consolidation. | |||||||||
Cash: | |||||||||
The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash. | |||||||||
Property and equipment: | |||||||||
Property and equipment are stated at cost and are depreciated, when placed into service, using the straight-line method over the estimated useful lives of the related assets, generally three to twenty years. The Company capitalizes all direct costs and all indirect incrementally identifiable costs related to the design and construction of its Integrated Projects. The Company reviews its property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. An impairment loss would be recognized based on the amount by which the carrying value of the assets or asset group exceeds its estimated fair value, and is recognized as a loss from operations. | |||||||||
Derivative Financial Instruments: | |||||||||
Pursuant to Accounting Standards Codification (“ASC”) Topic 815 “Derivatives and Hedging” (“Topic 815”), the Company reviews all financial instruments for the existence of features which may require fair value accounting and a related mark-to-market adjustment at each reporting period end. | |||||||||
Once determined, the Company assesses these instruments as derivative assets or liabilities. The fair value of these instruments is adjusted to reflect the fair value at each reporting period end, with any increase or decrease in the fair value being recorded in results of operations as an adjustment to fair value of derivatives. | |||||||||
Warrants: | |||||||||
The Company has issued warrants to purchase common shares of the Company. Warrants are valued using a fair value based method, whereby the fair value of the warrant is determined at the warrant issue date using a market-based option valuation model based on factors including an evaluation of the Company’s value as of the date of the issuance, consideration of the Company’s limited liquid resources and business prospects, the market price of the Company’s stock in its mostly inactive public market and the historical valuations and purchases of the Company’s warrants. When warrants are issued in combination with debt or equity securities, the warrants are valued and accounted for based on the relative fair value of the warrants in relation to the total value assigned to the debt or equity securities and warrants combined. | |||||||||
Concentrations of credit risk: | |||||||||
The Company's financial instruments that are exposed to concentrations of credit risk consist of cash. The Company's cash is in demand deposit accounts placed with federally insured financial institutions and selected brokerage accounts. Such deposit accounts at times may exceed federally insured limits. The Company has not experienced any losses on such accounts. | |||||||||
Noncontrolling interests: | |||||||||
In accordance with ASC 810, “Consolidation”, the Company separately classifies noncontrolling interests within the equity section of the consolidated balance sheets and separately reports the amounts attributable to controlling and noncontrolling interests in the consolidated statements of operations. In addition the noncontrolling interest continues to be attributed its share of losses even if that attribution results in a deficit noncontrolling interest balance. | |||||||||
Fair value measurements: | |||||||||
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date in the principal or most advantageous market. The Company uses a fair value hierarchy that has three levels of inputs, both observable and unobservable, with use of the lowest possible level of input to determine fair value. | |||||||||
Level 1 – quoted prices (unadjusted) in active markets for identical assets or liabilities; | |||||||||
Level 2 – observable inputs other than Level 1, quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, and model-derived prices whose inputs are observable or whose significant value drivers are observable; and | |||||||||
Level 3 – assets and liabilities whose significant value drivers are unobservable. | |||||||||
Observable inputs are based on market data obtained from independent sources, while unobservable inputs are based on the Company’s market assumptions. Unobservable inputs require significant management judgment or estimation. In some cases, the inputs used to measure an asset or liability may fall into different levels of the fair value hierarchy. In those instances, the fair value measurement is required to be classified using the lowest level of input that is significant to the fair value measurement. Such determination requires significant management judgment. | |||||||||
The fair value of cash and accounts payable approximates their carrying amounts due to their short-term maturities. The fair value of the loan payable approximates its carrying amount as it bears interest at rates commensurate with market rates. The fair value of the redeemable preferred stock approximates its carrying value due to the dividends accrued on the preferred stock which are reflected as part of the redemption value. The fair value of deferred compensation and loans payable – affiliates are not practicable to estimate due to the related party nature of the underlying transactions. | |||||||||
As of June 30, 2014, property and equipment was measured at estimated fair value on a non-recurring basis using level 3 inputs, which resulted in impairment (Note 3). | |||||||||
Revenue Recognition: | |||||||||
Revenues are generated from the sale of nutrient reduction credits. The Company recognizes revenue from the sale of nutrient credits when there is persuasive evidence that an arrangement exists, when title has passed, the price is fixed or determinable, and collection is reasonably assured. | |||||||||
The Company expects that technology license fees will be generated from the licensing of Bion’s integrated system. The Company anticipates that it will charge its customers a non-refundable up-front technology license fee, which will be recognized over the estimated life of the customer relationship. In addition, any on-going technology license fees will be recognized as earned based upon the performance requirements of the agreement. Annual waste treatment fees will be recognized upon receipt. Revenues, if any, from the Company’s interest in Integrated Projects will be recognized when the entity in which the Integrated Project has been developed recognizes such revenue. | |||||||||
Stock-based compensation: | |||||||||
The Company recognizes the cost of employee services received in exchange for an award of equity instruments in the financial statements and the cost is measured based on the grant date fair value of the award. The stock option compensation expense is recognized over the period during which an employee is required to provide service in exchange for the award (the requisite service period). The Company utilizes the Black-Scholes option-pricing model to determine fair value. Key assumptions of the Black-Scholes option-pricing model include applicable volatility rates, risk-free interest rates and the instrument’s expected remaining life. These assumptions require significant management judgment. | |||||||||
The Company has issued non-employee options that include service conditions and have graded vesting schedules. Generally for these arrangements, the measurement date of the services occurs when the options vest. Recognition of compensation cost for reporting periods prior to the measurement date is based on the then current fair value of the options. Fair value of the options is determined using a Black-Scholes option-pricing model. Any subsequent changes in fair value will be recorded on the measurement date. Compensation cost in connection with options that are not fully vested is being recognized on a straight-line basis over the requisite service period for the entire award. | |||||||||
Income taxes: | |||||||||
The Company recognizes deferred tax assets and liabilities for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their tax bases, as well as net operating losses. | |||||||||
Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets or liabilities of a change in tax rates is recognized in the period in which the tax change occurs. A valuation allowance is provided to reduce the deferred tax assets by 100%, since the Company believes that at this time it is more likely than not that the deferred tax asset will not be realized. | |||||||||
The Company is no longer subject to U.S. federal and state tax examinations for fiscal years before 2009. Management does not believe there will be any material changes in the Company’s unrecognized tax positions over the next 12 months. | |||||||||
The Company's policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. As of June 30, 2014, there were no penalties or accrued interest amounts associated with any unrecognized tax benefits, nor was any interest expense recognized during the years ended June 30, 2014 and 2013. | |||||||||
Loss per share: | |||||||||
Basic loss per share amounts are calculated using the weighted average number of shares of common stock outstanding during the period. Diluted loss per share assumes the conversion, exercise or issuance of all potential common stock instruments, such as options or warrants, unless the effect is to reduce the loss per share. During the years ended June 30, 2014 and 2013, the basic and diluted loss per share was the same, as the impact of potential dilutive common shares was anti-dilutive. | |||||||||
The following table represents the warrants, options and convertible securities excluded from the calculation of diluted loss per share: | |||||||||
June 30, | June 30, | ||||||||
2014 | 2013 | ||||||||
Warrants | 7,622,653 | 7,126,235 | |||||||
Options | 4,258,870 | 5,261,145 | |||||||
Convertible debt | 2,820,157 | 1,196,182 | |||||||
Convertible preferred stock | 13,000 | 12,000 | |||||||
The following is a reconciliation of the denominators of the basic loss per share computations for the years ended June 30, 2014 and 2013: | |||||||||
Year ended | Year ended | ||||||||
June 30, | June 30, | ||||||||
2014 | 2013 | ||||||||
Shares issued – beginning of period | 17,673,983 | 16,814,103 | |||||||
Shares held by subsidiaries (Note 8) | (704,309 | ) | (704,309 | ) | |||||
Shares outstanding – beginning of period | 16,969,674 | 16,109,794 | |||||||
Weighted average shares for fully vested stock bonuses (Note 8) | 840,000 | 821,507 | |||||||
Weighted average shares issued during the period | 826,690 | 384,135 | |||||||
Basic weighted average shares – end of period | 18,636,364 | 17,315,436 | |||||||
Use of estimates: | |||||||||
In preparing the Company’s consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. | |||||||||
Recent Accounting Pronouncements: | |||||||||
The Company has evaluated all newly issued accounting pronouncements and believes such pronouncements do not have a material effect on the Company’s financial statements. |
Note_3_Property_and_Equipment
Note 3 - Property and Equipment: | 12 Months Ended | ||||||||
Jun. 30, 2014 | |||||||||
Property, Plant and Equipment [Abstract] | ' | ||||||||
Property, Plant and Equipment Disclosure [Text Block] | ' | ||||||||
3 | PROPERTY AND EQUIPMENT: | ||||||||
Property and equipment consists of the following: | |||||||||
June 30, | June 30, | ||||||||
2014 | 2013 | ||||||||
Machinery and equipment | $ | 4,111,001 | $ | 5,432,947 | |||||
Buildings and structures | 1,947,701 | 2,574,010 | |||||||
Leasehold improvements | - | 31,336 | |||||||
Furniture | - | 28,932 | |||||||
Computers and office equipment | 183,809 | 243,058 | |||||||
6,242,511 | 8,310,283 | ||||||||
Less accumulated depreciation | (1,891,358 | ) | (979,263 | ) | |||||
$ | 4,351,153 | $ | 7,331,020 | ||||||
During the year ended June 30, 2013, Kreider 1 was placed into service and the capitalized costs of $8,219,617 were allocated among its separately identifiable components. Depreciation expense was $978,798 and $905,871 for the years ended June 30, 2014 and 2013, respectively. | |||||||||
Management reviewed property and equipment for impairment as of June 30, 2014 and determined that the carrying amount of property and equipment related to the Kreider 1 project exceeded its estimated future undiscounted cash flows. Management estimated the fair value of the property and equipment, based on the discounted cash flow method, and determined that $2,000,000 of the property and equipment was impaired. |
Note_4_Loans_Payable_Affiliate
Note 4 - Loans Payable - Affiliates: (Loans Payable - Affiliates [Member]) | 12 Months Ended | |
Jun. 30, 2014 | ||
Loans Payable - Affiliates [Member] | ' | |
Note 4 - Loans Payable - Affiliates: [Line Items] | ' | |
Related Party Transactions Disclosure [Text Block] | ' | |
4 | LOANS PAYABLE - AFFILIATES: | |
As of June 30, 2014, Dominic Bassani (“Bassani”), the Company’s Chief Executive Officer (“CEO”), has loaned the Company $200,000 for fiscal year 2013 working capital needs (“FY 2013 Loan”). The FY 2013 Loan bears interest at 8% per annum and was payable on August 31, 2013. The due date of the FY 2013 Loan plus accrued interest was extended to September 30, 2013. Subsequent to September 30, 2013, the FY 2013 Loan was extended to January 1, 2014 and then further extended to April 30, 2014 and then again to July 1, 2014. During September 2014, the maturity date of the FY 2013 Loan was extended to January 1, 2015. Conversion terms substantially identical to those described in Note 7 have been added to the terms of the FY 2013 Loan. Interest expense related to the FY 2013 Loan was $16,318 and $6,618 for the years ended June 30, 2014 and 2013, respectively. | ||
During the year ended June 30, 2014, Bassani loaned the Company $19,000 (“November Note”). The November Note bears interest at 8% per annum and was payable on February 28, 2014, but was extended to April 30, 2014, and then further extended to July 1, 2014. During September 2014, the maturity date of the November Note was extended to January 1, 2015. Interest expense related to the November Note was $904 and nil for the years ended June 30, 2014 and 2013, respectively. | ||
During the year ended June 30, 2014, the Company entered into promissory note agreements (“December Notes”) with Bassani and a major shareholder (“Shareholder”) whereby Bassani and Shareholder agreed to lend the Company up to $75,000 each for working capital needs. The December Notes bear interest at 8% per annum and were payable on March 31, 2014. However, since the Company did not have sufficient funds for working capital needs to allow repayment of the December Notes on March 31, 2014, the maturity date of the December Notes was extended for three months; which process may be repeated up to three additional times with the maturity date extended to a date as late as December 31, 2014. In consideration for the December Notes, the Company issued warrants to purchase up to 18,750 shares of the Company’s common stock at $0.85 per share until December 31, 2018 (proportionately reduced if the December Notes are funded for less than the $75,000 maximum). Additional warrants (in the same amount and terms) will be issued upon each extension of the maturity date of the December Notes. The warrants will vest immediately upon issuance. As of June 30, 2014, Bassani and Shareholder had loaned the Company $60,000 and $75,000, respectively, under the terms of the December Notes. Interest expense related to the December Notes was $5,211 and nil for the years ended June 30, 2014 and 2013, respectively. The maturity date of the December Notes has been extended to September 30, 2014. During the year ended June 30, 2014, the Company issued 105,000 warrants to purchase 105,000 shares of the Company’s common stock at $0.85 per share and has recorded interest expense of $10,500 and nil for the years ended June 30, 2014 and 2013, respectively. | ||
During the year ended June 30, 2014, Mark A. Smith (“Smith”), the Company’s President loaned the Company $10,000 for working capital needs. The loan was non-interest bearing and has been added to Smith’s convertible note payable (Note 7). |
Note_5_Deferred_Compensation
Note 5 - Deferred Compensation: | 12 Months Ended | |
Jun. 30, 2014 | ||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ' | |
Disclosure of Compensation Related Costs, Share-based Payments [Text Block] | ' | |
5 | DEFERRED COMPENSATION: | |
The Company owes Edward Schafer (“Schafer”), the Company’s Executive Vice Chairman, two employees and two former employees, aggregate deferred compensation of $485,734 as of June 30, 2014 (subject to the outcome of pending litigation – see Note 13). The majority of the balance is payable dependent upon the cash reserves of the Company and $984 was paid by the issuance of 807 shares of the Company’s common shares in July 2014. | ||
As of June 30, 2014, the Company owed Bassani deferred compensation of $231,000 including interest of $66,000, which was due and payable on July 1, 2014 but has been extended until January 1, 2015. The deferred compensation accrues interest at 10% per annum and is convertible into the Company’s restricted common stock at $1.50 per share. |
Note_6_Loan_Payable
Note 6 - Loan Payable: | 12 Months Ended | |
Jun. 30, 2014 | ||
Debt Disclosure [Abstract] | ' | |
Debt Disclosure [Text Block] | ' | |
6 | LOAN PAYABLE: | |
As of June 30, 2014, PA-1, the Company’s wholly-owned subsidiary, owes $7,754,000 under the terms of the Pennvest Loan related to the construction of the Kreider 1 System. The terms of the Pennvest Loan provide for funding of up to $7,754,000 which is to be repaid by interest-only payments for three years, followed by an additional ten-year amortization of principal. The Pennvest Loan accrues interest at 2.547% for years 1 through 5 and 3.184% for years 6 through maturity. The Pennvest Loan requires minimum annual principal payments of approximately $574,000 in fiscal year 2013, $704,000 in fiscal year 2014, $723,000 in fiscal year 2015, $741,000 in fiscal year 2016, $760,000 in fiscal year 2017 and $4,252,000 thereafter. The Pennvest Loan is collateralized by the Kreider 1 System and by a pledge of all revenues generated from Kreider 1 including, but not limited to, revenues generated from nutrient reduction credit sales and by-product sales. In addition, in consideration for the excess credit risk associated with the project, Pennvest is entitled to participate in the profits from Kreider 1 calculated on a net cash flow basis, as defined. The Company has incurred interest expense related to the Pennvest Loan of $197,494 for each of the years ended June 30, 2014 and 2013, of which nil and $15,793 has been capitalized as a cost of Kreider 1 for the years ended June 30, 2014 and 2013, respectively. Based on the limited development of the depth and breadth of the Pennsylvania nutrient reduction credit market to date, PA-1 has commenced negotiations with Pennvest related to forbearance and/or re-structuring the obligations under the Pennvest Loan. In the context of such negotiations, PA-1 has elected not to make interest payments to Pennvest on the Pennvest Loan since January 2013. Additionally, the Company has not made any principal payments, which were to begin in fiscal 2013, and, therefore, the Company has classified the Pennvest Loan as a current liability as of June 30, 2014. Due to the slow development of the nutrient reduction credit market, the Company determined that the carrying amount of the property and equipment related to the Kreider 1 project exceeded its estimated future undiscounted cash flows based on certain assumptions regarding timing, level and probability of revenues from sales of nutrient reduction credits and, therefore, recorded a $2,000,000 impairment of the Kreider 1 assets which reduced the value of the Kreider 1 System to $4,349,482 as of June 30, 2014. Additional impairments may result if the nutrient credit market does not develop in the near term. | ||
On September 25, 2014 Pennvest exercised its right to declare the Pennvest Loan in default and has accelerated the Pennvest Loan and has demanded that PA-1 pay $8,137,117 (principal, interest plus late charges) on or before October 24, 2014. The Company anticipates that discussions and negotiations will take place between PA-1 and Pennvest concerning this matter of the next 30 days. It is not possible at this date to predict the outcome of such negotiations but the Company believes that an interim, short-term agreement will be reached that will allow PA-1 and Pennvest a further period of time for further negotiations and evaluation of possible long term resolutions. Subject to the results of the negotiations with Pennvest and pending development of a more robust market for nutrient reductions in Pennsylvania, PA-1 and Bion anticipate that it will be necessary for the Company to evaluate various options with regard to Kreider 1 over the next 30-180 days. | ||
During August 2012 the Company provided Pennvest (and the PADEP) with data demonstrating that the Kreider 1 system met the ‘technology guaranty’ standards which were incorporated in the Pennvest financing documents and, as a result, the Pennvest Loan is now solely an obligation of PA-1. | ||
Additionally, the Company has not made any principal payments, which were to begin in fiscal 2013. Although Pennvest has not declared the Pennvest Loan in default, the Company has classified the Pennvest Loan as a current liability as of June 30, 2014. It is not possible at this date to predict the outcome of negotiations with Pennvest. Management reviewed property and equipment for impairment as of June 30, 2014 and determined that the carrying amount of property and equipment related to the Kreider 1 project exceeded its estimated future undiscounted cash flows. Management estimated the fair value of the property and equipment based on the discounted cash flow method, and determined that $2,000,000 of the property and equipment was impaired. Subject to the results of the negotiations and pending development of a more robust market for nutrient reduction credits in Pennsylvania, Bion anticipates that it will be necessary to evaluate various options with regard to Kreider 1. | ||
In connection with the Pennvest Loan, the Company provided a ‘technology guaranty’ regarding nutrient reduction performance of Kreider 1 which was structured to expire when Kreider 1’s nutrient reduction performance had been demonstrated. On August 1, 2012 the Company informed Pennvest and the PADEP (with supporting performance data) that the Kreider 1 System had surpassed the requisite performance criteria and that, as a result, the Company’s ‘technology guaranty’ was met. |
Note_7_Convertible_Notes_Payab
Note 7 - Convertible Notes Payable - Affiliates | 12 Months Ended | |
Jun. 30, 2014 | ||
Convertible Debt [Text Block] [Abstract] | ' | |
Convertible Debt [Text Block] | ' | |
7 | CONVERTIBLE NOTES PAYABLE - AFFILIATES: | |
Effective May 15, 2013, the Board of Directors approved agreements with Bassani and Smith, under which, Bassani and Smith have agreed to continue to defer their cash compensation up to April 30, 2014 (unless the Board of Directors elects to re-commence cash payment on an earlier date) and to extend the due date of their deferred cash compensation until January 15, 2015. The agreements have been evidenced in the form of convertible promissory notes (“Convertible Notes”). During the year ended June 30, 2014, Bassani and Smith have agreed to continue to defer their cash compensation up to July 1, 2014. During September 2014, Bassani and Smith have agreed to continue to defer their cash compensation up to January 1, 2015. | ||
The Convertible Notes accrue interest at 8% per annum and are due and payable on January 15, 2015. The Convertible Notes (including accrued interest) of $742,057 and $994,445 at June 30, 2014 owed to Smith and Bassani, respectively, plus all future deferred compensation or other sums subsequently added to the principal of the Convertible Notes, may be converted, at the sole election of Smith and Bassani, into Units consisting of one share of the Company’s common stock and one warrant to purchase a share of the Company’s common stock, at a price of $1.25 per Unit until January 15, 2015. The warrant contained in the Unit shall be exercisable at $2.50 per share until December 31, 2018. As the original conversion price of $1.25 per Unit approximated the fair value of the Units at the date of the agreements, no beneficial conversion feature exists at June 30, 2014. Pursuant to the deferral agreements, the conversion price of the Convertible Notes plus accrued interest is the lower of the $1.25 per Unit price or the lowest price at which the Company sells its common stock on or before January 15, 2015. As of June 30, 2014, the lowest price at which the Company had sold its common stock during the relevant period is $0.75 per share. Management evaluated the terms and conditions of the embedded conversion features based on the guidance of ASC 815-15 “Embedded Derivatives” to determine if there was an embedded derivative requiring bifurcation. An embedded derivative instrument (such as a conversion option embedded in the deferred compensation) must be bifurcated from its host instruments and accounted for separately as a derivative instrument only if the “risks and rewards” of the embedded derivative instrument are not “clearly and closely related” to the risks and rewards of the host instrument in which it is embedded. Management concluded that the embedded conversion feature of the deferred compensation was not required to be bifurcated because the conversion feature is clearly and closely related to the host instrument, and because of the Company’s limited trading volume that indicates the feature is not readily convertible to cash in accordance with ASC 815-10, “Derivatives and Hedging”. During the year ended June 30, 2014, Smith elected to convert $187,500 of his Convertible Note, at a conversion price of $0.75, into 250,000 Units consisting of 250,000 shares of the Company’s common stock and 250,000 warrants. As of June 30, 2014, the Company owes Smith, $742,057 under the terms of his Convertible Note. The Convertible Note is comprised of deferred compensation of $671,468 and accrued interest of $70,589. During the year ended June 30, 2014, Bassani elected to convert $110,000 of his Convertible Note, at a conversion price of $0.84, into 130,953 Units consisting of 130,953 shares of the Company’s common stock (which were not issued as of June 30, 2014) and 130,953 warrants. As of June 30, 2014, the Company owes Bassani, $994,445, comprised of deferred compensation of $878,000 and accrued interest of $116,445, under the terms of his Convertible Note. | ||
As part of the agreements, Bassani and Smith have also forgiven any possible obligations that Bion may have owed each of them in relation to unused vacation time for periods (over 10 years) prior to the year ended June 30, 2012. In consideration of these agreements, Bassani and Smith: a) have been granted 50% ‘execution/exercise’ bonuses to be effective upon future exercise of outstanding (or subsequently acquired) options and warrants owned by Bassani and Smith (and their respective donees) and in relation to contingent stock bonuses (see Note 13 for further details); b) warrants and options, if due to expire prior to December 31, 2018, have been extended to that date (with possible further extensions) and c) other modifications have been made to existing agreements. |
Note_8_Stockholders_Equity
Note 8 - Stockholders' Equity: | 12 Months Ended | ||||||||||||||||
Jun. 30, 2014 | |||||||||||||||||
Stockholders' Equity Note [Abstract] | ' | ||||||||||||||||
Stockholders' Equity Note Disclosure [Text Block] | ' | ||||||||||||||||
8 | STOCKHOLDERS' EQUITY: | ||||||||||||||||
Series B Preferred stock: | |||||||||||||||||
At July 1, 2012, the Company had 450 shares of Series B redeemable convertible Preferred stock outstanding with a par value of $0.01 per share, convertible at the option of the holder at $2.00 per share, with dividends accrued and payable at 2.5% per quarter. The Series B Preferred stock is mandatorily redeemable at $2.00 per share by the Company three years after issuance and accordingly was classified outside of shareholders’ equity. | |||||||||||||||||
During the year ended June 30, 2013 the Company redeemed 250 shares of its Series B Preferred stock plus accrued dividends of $2,500 for $27,500. The remaining 200 shares have reached their maturity date, but due to the cash constraints of the Company have not been redeemed as of September 23, 2014. | |||||||||||||||||
During the years ended June 30, 2014 and 2013, the Company declared dividends of $2,000 and $2,417 respectively. At June 30, 2014, accrued dividends payable are $6,000. | |||||||||||||||||
Series C Preferred stock: | |||||||||||||||||
At July 1, 2012 the Company had 300 shares of Series C Preferred stock outstanding, which have a par value of $0.01 per share and were convertible at the option of the holder at any time from the date of issuance, into shares of the Company’s common stock calculated by dividing the sum of the $100 per share purchase price plus any accrued and unpaid dividends by $4.00 (the Conversion Rate), provided the shares have not been redeemed into common shares by the Company at is sole election. | |||||||||||||||||
During the year ended June 30, 2012, the Company offered its Series C Preferred stockholders the ability to participate in a Series C Preferred Stock Conversion Subscription Agreement (“Series C Conversion Agreement”) pursuant to which the Series C Preferred stockholders agreed to convert Series C Preferred shares plus accrued dividends into restricted common stock of the Company at a conversion price of $3.00 per share. The conversion price of $3.00 per share represented a $1.00 per share reduction from the original terms of the Series C Preferred stock and due to the limited time in which the Series C stockholders had to subscribe to the Series C Conversion Agreement, the reduction in the conversion price was accounted for as an inducement. Pursuant to the Series C Conversion Agreement the Company paid fees to any licensed/registered broker(s)/advisor(s) who assisted in the conversion process and issued one warrant for each 10 shares received by the participating Series C stockholders. Each warrant allows for the purchase of one share of the Company’s restricted common stock at $3.10 per share until expiration on December 31, 2014. | |||||||||||||||||
During the year ended June 30, 2013, one of the Company’s Series C Preferred stockholders asked to convert their shares under the Series C Conversion Agreement. The Company agreed to honor the Series C Conversion Agreement on February 15, 2013, pursuant to which a total of 300 shares of Series C Preferred stock and accrued dividends of $5,000 were converted into 11,667 shares of common stock and 1,167 warrants were issued to a broker. The Company allocated the value between the restricted common stock and the warrants based upon their relative fair value to the total value of the issuances using the share price of the common stock on the day of the conversion and the value of the warrants, which was determined to be $0.075 per warrant. As a result, $155 and $40,591 was allocated to the warrants and restricted common stock, respectively, all of which was recorded as additional paid-in capital. The Company paid commissions of $116 related to the conversion which resulted in a reduction of additional paid-in capital. The Company recorded $5,746 related to the conversion inducement of the Series C stock, which is reflected as part of the value of the Series C Preferred stock with an offset to reduce additional paid-in capital, and is included in the determination of net loss applicable to common stockholders for the year ended June 30, 2013. | |||||||||||||||||
During the years ended June 30, 2014 and 2013, the Company declared dividends of nil and $2,000 respectively. At June 30, 2014 dividends payable are nil. | |||||||||||||||||
Common stock: | |||||||||||||||||
Holders of common stock are entitled to one vote per share on all matters to be voted on by common stockholders. In the event of liquidation, dissolution or winding up of the Company, the holders of common stock are entitled to share in all assets remaining after liabilities have been paid in full or set aside and the rights of any outstanding preferred stock have been satisfied. Common stock has no preemptive, redemption or conversion rights. The rights of holders of common stock are subject to, and may be adversely affected by, the rights of the holders of any outstanding series of preferred stock or any series of preferred stock the Company may designate in the future. | |||||||||||||||||
Centerpoint holds 704,309 shares of the Company’s common stock. These shares of the Company’s common stock held by Centerpoint are for the benefit of its shareholders without any beneficial interest. The Company accounts for these shares similar to treasury stock. | |||||||||||||||||
During the year ended June 30, 2013, the Company issued 124,157 shares of the Company’s restricted common stock at prices ranging from $1.56 to $2.13 per share for consulting services valued at $148,140, in the aggregate, to consultants and an employee. | |||||||||||||||||
During the year ended June 30, 2013, the Company granted Bassani and Smith shares of the Company’s common stock as bonuses for signing extensions to their employment agreements. Bassani will be issued 300,000 shares of the Company’s common stock issuable in two tranches of 150,000 shares on each of January 1, 2015 and 2016, respectively. Smith will be issued 150,000 shares of the Company’s common shares in two tranches of 75,000 shares on each of January 15, 2014 (issued) and 2015, respectively. The Company recorded non-cash compensation of $585,000 and $292,500 related to the future stock issuances to Bassani and Smith, respectively, as the bonuses were fully vested upon grant date during the year ended June 30, 2013. | |||||||||||||||||
During the year ended June 30, 2013, the Company declared contingent stock bonuses of 25,000 and 100,000 shares to Schafer and Smith, respectively, and recognized $48,750 and $195,000 of non-cash compensation expense, respectively. The stock bonuses are contingent upon the Company’s stock price exceeding $10.00 and do not require that Schafer or Smith remain employed by the Company. | |||||||||||||||||
During the year ended June 30, 2013, the Company entered into subscription agreements to sell 2012 B UNITS for $2.25 each, with each 2012 B UNIT consisting of one 2012 B share of the Company’s restricted common stock and one 2012 B warrant to purchase one half of a share of the Company’s restricted common stock for $3.10 per share until December 31, 2014 (the “2012 B UNITS”). During the year ended June 30, 2013, the Company issued 177,556 2012 B UNITS for total proceeds of $399,499. The Company allocated the proceeds from the 2012 B shares and the 2012 B warrants based upon their relative fair values, using the share price on the day each of the subscription agreements were entered into and the fair value of the 2012 B Warrants, which was determined to be $0.075 per 2012 B Warrant. As a result, $6,905 was allocated to the 2012 B Warrants and $392,594 was allocated to the 2012 B Shares, and both were recorded as additional paid in capital. | |||||||||||||||||
During the year ended June 30, 2013, the Company entered into subscription agreements to sell 2013 UNITS for $2.00 each, with each 2013 UNIT consisting of one 2013 Share of the Company’s restricted common stock and one 2013 Warrant to purchase one half of a share of the Company’s restricted common stock for $2.50 per share until December 31, 2014 (the “2013 UNITS”). During the year ended June 30, 2013, the Company issued 330,500 2013 UNITS for total proceeds of approximately $661,000. The Company allocated the proceeds from the 2013 shares and the 2013 warrants based upon their relative fair values, using the share price on the day each of the subscription agreements were entered into and the fair value of the 2013 Warrants, which was determined to be $0.075 per 2013 Warrant. As a result, $12,262 was allocated to the 2013 Warrants and $648,738 was allocated to the 2013 Shares, and both were recorded as additional paid in capital. | |||||||||||||||||
During the year ended June 30, 2013, the Company sold 216,000 shares of the Company’s restricted common stock for total net proceeds of $292,375 (including subscriptions receivable of $25,000 for 20,000 shares at June 30, 2013, all of which was received in July 2013). | |||||||||||||||||
During the year ended June 30, 2014, the Company issued 360,066 shares of the Company’s common stock at prices ranging from $0.75 to $1.85 per share for consulting services valued at $307,102, in the aggregate, to consultants and employees, including 120,000 shares of fully vested bonus shares granted to Mr. Smith in fiscal years 2012 and 2013 which were expensed at grant date. | |||||||||||||||||
During the year ended June 30, 2014, the Company issued 13,369 shares of the Company’s common stock at prices ranging from $1.46 to $1.51 per share for accounts payable of $19,940. | |||||||||||||||||
During the year ended June 30, 2014, the Company issued 250,000 shares of the Company’s common stock upon Smith’s and Bassani’s election to convert $187,500 and $110,000, respectively, of their convertible note payable – affiliate into Units at a conversion prices of $0.75 and $0.84 per Unit, respectively (Note 7). | |||||||||||||||||
During the year ended June 30, 2014, the Company sold 592,534 shares of the Company’s restricted common stock at $0.75 per share for total proceeds of $474,400, net proceeds of $467,575 (including subscriptions receivable of $30,000 for 40,000 shares at June 30, 2014, all of which was received in July 2014). | |||||||||||||||||
During the year ended June 30, 2014, the Company sold 400,000 shares of the Company’s restricted common stock at $1.25 per share for total net proceeds of $500,000. The subscription agreement for the sale of these shares included a provision whereby the subscription agreement would be modified if the Company issued securities on more favorable terms prior to December 31, 2014. As such the Company issued an additional 266,667 common shares to the subscriber during the year ended June 30, 2014 due to the sale of common stock at $0.75 per share. | |||||||||||||||||
The Company also issued 20,000 shares of the Company’s restricted common stock upon receipt of its subscription receivable of $25,000 during the year ended June 30, 2014. | |||||||||||||||||
Warrants: | |||||||||||||||||
As of June 30, 2014, the Company had approximately 7.6 million warrants outstanding, with exercise prices from $0.75 to $4.25 and expiring on various dates through January 15, 2019. | |||||||||||||||||
The weighted-average exercise price for the outstanding warrants is $2.18, and the weighted-average remaining contractual life as of June 30, 2014 is 3.75 years. | |||||||||||||||||
During the year ended June 30, 2013 warrants to purchase 50,000 and 250,000 shares of the Company’s common stock at $2.10 per share were issued pursuant to extension agreements with Bassani and Smith, respectively (Note 12). These warrants were determined to have a fair value of $0.10 per warrant and expire on December 31, 2018. The Company recorded non-cash compensation expense of $5,000 and $25,000, respectively, related to the warrant issuances. | |||||||||||||||||
During the year ended June 30, 2013, the Company issued warrants to purchase 88,779 and 165,250 shares of the Company’s common stock in connection with the sale of 2012 B UNITS and 2013 UNITS, respectively. | |||||||||||||||||
During the year ended June 30, 2013 warrants to purchase 68,786 shares of the Company’s common stock at prices ranging from $1.68 to $2.50 per share were issued pursuant to an agreement with a consultant. The warrants were determined to have a fair value of $0.10 per warrant and expire five years from date of issuance. The Company recorded non-cash compensation expense of $6,879 related to the warrant issuances. The Company entered into an agreement with the consultant whereby 38,786 of these warrants carry an exercise bonus equal to 75% of the exercise price to be offset against the exercise price if exercised after 24 months from the issuance of the warrants. | |||||||||||||||||
During the year ended June 30, 2013, the Company issued 1,167 warrants in connection with the conversion of Series C Preferred Stock. | |||||||||||||||||
During the year ended June 30, 2013 the Company agreed to extend the expiration date of 166,500 warrants owned by Bassani and Smith (and their respective donees) (Note 7 and 13) which were scheduled to expire prior to December 31, 2018 to that date. The company recorded expense related to the modification of the warrants of $8,325 for the year ended June 30, 2013. | |||||||||||||||||
As of June 30, 2013, 5,419,324 of the warrants of the Company are subject to execution/exercise bonuses under agreements with Bassani, Smith and Schafer (Note 13). The modification of the warrants under the execution/exercise bonuses for Smith and Bassani resulted in an incremental non-cash compensation expense of approximately $1,885,000 for the year ended June 30, 2013. | |||||||||||||||||
During the year ended June 30, 2014 warrants to purchase 35,465 shares of the Company’s common stock at prices ranging from $1.12 to $1.71 per share were issued pursuant to an agreement with a consultant. The warrants were determined to have a fair value of $0.10 per warrant and expire five years from date of issuance. The Company recorded non-cash compensation expense of $3,546 related to the warrant issuances. The Company entered into an agreement with the consultant whereby the 35,465 warrants issued during the year ended June 30, 2014 and 38,786 warrants previously issued carry an exercise bonus equal to 75% of the exercise price to be offset against the exercise price if exercised after 24 months from the issuance of the warrants. | |||||||||||||||||
During the year ended June 30, 2014, warrants to purchase 105,000 shares of the Company’s common stock at $0.85 per share were issued pursuant the promissory notes entered into by Bassani and Shareholder (Note 4). The warrants were determined to have a fair value of $0.10 per warrant and expire on December 31, 2018. The Company recorded interest expense of $10,500 related to the warrant issuances. | |||||||||||||||||
During the year ended June 30, 2014, the Company issued 250,000 warrants to purchase common stock of the Company at $2.50 per share with December 31, 2018 expiry dates, due to Smith’s election to convert $187,500 of his convertible note payable – affiliate into Units at a conversion price of $0.75 per Unit (Note 7). | |||||||||||||||||
During the year ended June 30, 2014, the Company issued 130,953 warrants to purchase common stock of the Company at $2.50 per share with December 31, 2018 expiry dates, due to Bassani’s election to convert $110,000 of his convertible note payable – affiliate into Units at a conversion price of $0.84 per Unit (Note 7). | |||||||||||||||||
During the year ended June 30, 2014, warrants to purchase 25,000 common stock of the Company at $2.00 per share expired. | |||||||||||||||||
As of June 30, 2014, 5,874,528 of the warrants of the Company are subject to execution/exercise bonuses under agreements with Bassani and Smith (Note 13). | |||||||||||||||||
Stock options: | |||||||||||||||||
The Company’s 2006 Consolidated Incentive Plan (the “2006 Plan”), as amended effective May 1, 2014, provides for the issuance of options to purchase up to 17,000,000 shares of the Company’s common stock. Terms of exercise and expiration of options granted under the 2006 Plan may be established at the discretion of the Board of Directors, but no option may be exercisable for more than ten years. | |||||||||||||||||
In May 2013, the Company entered into an agreement with an officer of the Company (Notes 7 and 12) which entitled the employee to modifications of existing stock options resulting in the extension of certain expiration dates and resulted in incremental non-cash compensation expense of approximately $49,700 for the year ended June 30, 2013. | |||||||||||||||||
The Company entered into agreements with Smith and Bassani, pursuant to which each is entitled to execution/exercise bonuses. The modification of the options for Smith and Bassani under the execution/exercise bonuses resulted in an incremental non-cash compensation expense of approximately $562,000 for the year ended June 30, 2013. | |||||||||||||||||
In July 2013, the Company entered into an agreement with a terminated employee which entitled the former employee to modifications of existing stock options resulting in the extension of certain expiration dates and resulting in incremental non-cash compensation expense of $97,125 for the year ended June 30, 2014. | |||||||||||||||||
During the year ended June 30, 2014, the Company entered into agreements with Schafer and a board member, pursuant to which each is entitled to execution/exercise bonuses identical to those previously offered to Bassani and Smith (Note 12). The modification of the options for Schafer and the board member resulted in incremental non-cash compensation expense of $210,513 for the year ended June 30, 2014. As of June 30, 2014, 2,295,000 of the outstanding options of the Company are subject to execution/exercise bonuses. | |||||||||||||||||
The Company recorded compensation expense/(credits) related to employee stock options of $(204,257) and $455,080 for the years ended June 30, 2014 and 2013, respectively. The Company granted 97,725 and 150,000 options during the years ended June 30, 2014 and 2013, respectively. | |||||||||||||||||
During the year ended June 30, 2014, 200,000 options were forfeited and 900,000 options expired. | |||||||||||||||||
The fair value of the options granted during the years ended June 30, 2014 and 2013 were estimated on the grant date using the Black-Scholes option-pricing model with the following assumptions: | |||||||||||||||||
Weighted | Range, | Weighted | Range, | ||||||||||||||
average, | 30-Jun-14 | average, | 30-Jun-13 | ||||||||||||||
30-Jun-14 | 30-Jun-13 | ||||||||||||||||
Volatility | 54 | % | 49%-65 | % | 66 | % | 60%-68 | % | |||||||||
Dividend yield | - | - | - | - | |||||||||||||
Risk-free interest rate | 0.95 | % | 0.59%-1.69 | % | 0.32 | % | 0.31%-0.34 | % | |||||||||
Expected term (years) | 3.29 | 2.63-4.67 | 3.05 | 2.66-3.25 | |||||||||||||
The expected volatility was based on the historical price volatility of the Company’s common stock. The dividend yield represents the Company’s anticipated cash dividend on common stock over the expected term of the stock options. The U.S. Treasury bill rate for the expected term of the stock options was utilized to determine the risk-free interest rate. The expected term of stock options represents the period of time the stock options granted are expected to be outstanding based upon management’s estimates. | |||||||||||||||||
A summary of option activity under the 2006 Plan for the two years ended June 30, 2014 is as follows: | |||||||||||||||||
Options | Weighted- | Weighted- | Aggregate | ||||||||||||||
Average | Average | Intrinsic | |||||||||||||||
Exercise | Remaining | Value | |||||||||||||||
Price | Contractual | ||||||||||||||||
Life | |||||||||||||||||
Outstanding at July 1, 2012 | 5,111,145 | $ | 2.86 | 4.6 | $ | - | |||||||||||
Granted | 150,000 | 2.1 | |||||||||||||||
Exercised | - | - | |||||||||||||||
Forfeited | - | - | |||||||||||||||
Expired | - | - | |||||||||||||||
Outstanding at June 30, 2013 | 5,261,145 | 2.84 | 4 | - | |||||||||||||
Granted | 97,725 | 1.35 | |||||||||||||||
Exercised | - | - | |||||||||||||||
Forfeited | (200,000 | ) | 3 | ||||||||||||||
Expired | (900,000 | ) | 2.84 | ||||||||||||||
Outstanding at June 30, 2014 | 4,258,870 | $ | 2.81 | 3.2 | $ | 10,500 | |||||||||||
Exercisable at June 30, 2014 | 4,258,870 | $ | 2.81 | 3.2 | $ | 10,500 | |||||||||||
The following table presents information relating to nonvested stock options as of June 30, 2014: | |||||||||||||||||
Options | Weighted Average | ||||||||||||||||
Grant-Date Fair | |||||||||||||||||
Value | |||||||||||||||||
Nonvested at July 1, 2013 | 325,000 | $ | 1.86 | ||||||||||||||
Granted | 97,725 | 0.58 | |||||||||||||||
Vested | (222,725 | ) | (1.08 | ) | |||||||||||||
Forfeited | (200,000 | ) | (2.10 | ) | |||||||||||||
Nonvested at June 30, 2014 | - | $ | - | ||||||||||||||
The total fair value of stock options that vested during the years ended June 30, 2014 and 2013 was $54,022 and $599,650, respectively. As of June 30, 2014, the Company had no unrecognized compensation cost related to stock options. | |||||||||||||||||
Stock-based employee compensation charges in operating expenses in the Company’s financial statements for the years ended June 30, 2014 and 2013 are as follows: | |||||||||||||||||
Year ended | Year ended | ||||||||||||||||
June 30, | June 30, | ||||||||||||||||
2014 | 2013 | ||||||||||||||||
General and administrative: | |||||||||||||||||
Fair value of stock/warrant bonuses expensed | $ | - | $ | 1,159,575 | |||||||||||||
Fair value of stock issued to an employee | 94,998 | 99,996 | |||||||||||||||
Change in fair value from modification of option terms | 307,638 | 2,496,700 | |||||||||||||||
Fair value of stock options (credited)/expensed | (87,517 | ) | 416,804 | ||||||||||||||
Total | $ | 315,119 | $ | 4,173,075 | |||||||||||||
Research and development: | |||||||||||||||||
Fair value of stock options (credited)/expensed | $ | (116,739 | ) | $ | 38,276 | ||||||||||||
Total | $ | (116,739 | ) | $ | 38,276 | ||||||||||||
Note_9_Gain_on_Extinguishment_
Note 9 - Gain on Extinguishment of Liabilities: | 12 Months Ended | |
Jun. 30, 2014 | ||
Gain On Extinguishment Of Liabilities [Text Block] [Abstract] | ' | |
Gain On Extinguishment Of Liabilities [Text Block] | ' | |
9 | GAIN ON EXTINGUISHMENT OF LIABILITIES: | |
During the year ended June 30, 2014, the Company recognized other income due to the extinguishment of liabilities of $20,113, resulting from the legal release of certain accounts payable. These accounts payable, which related to business activities of the Company discontinued during the 2008 fiscal year, were outstanding for 5-6 years and the vendor had made no attempt to collect these amounts from the Company over the past several years. The extinguishment of liabilities was recorded after a review of the statute of limitations in the state in which the original liability was incurred. |
Note_10_Operating_Lease
Note 10 - Operating Lease: | 12 Months Ended | |
Jun. 30, 2014 | ||
Leases, Operating [Abstract] | ' | |
Operating Leases of Lessor Disclosure [Text Block] | ' | |
10 | OPERATING LEASE: | |
The Company entered into an agreement effective September 26, 2013 whereby the Company assigned its rights, title and interest as a tenant of it non-cancellable operating lease commitment for office space in New York, effective August 1, 2006 and expiring November 30, 2013. In conjunction with the assignment of its lease, the Company was released from its obligation to the lessor of its secured letter of credit. Pursuant to the Master Sublease entered into with Mr. Salvatore Zizza, a former officer and director of the Company effective January 1, 2009, Mr. Zizza was entitled to the previously restricted funds securing the letter of credit of $57,315. Mr. Zizza was paid the $57,315 in October 2013. |
Note_11_Income_Taxes
Note 11 - Income Taxes: | 12 Months Ended | ||||||||
Jun. 30, 2014 | |||||||||
Income Tax Disclosure [Abstract] | ' | ||||||||
Income Tax Disclosure [Text Block] | ' | ||||||||
11 | INCOME TAXES: | ||||||||
The reconciliation between the expected federal income tax benefit computed by applying the Federal statutory rate to loss before income taxes and the actual benefit for taxes on loss for the years ended June 30, 2014 and 2013 is as follows: | |||||||||
2014 | 2013 | ||||||||
Expected income tax benefit at statutory rate | $ | (1,959,000 | ) | $ | (2,805,000 | ) | |||
State taxes, net of federal benefit | (177,000 | ) | (252,000 | ) | |||||
Permanent differences and other | (19,000 | ) | (28,000 | ) | |||||
Expiration of NOLs | - | - | |||||||
Change in valuation allowance | 2,155,000 | 3,085,000 | |||||||
Income tax benefit | $ | - | $ | - | |||||
The Company has net operating loss carry-forwards (“NOLs”) for tax purposes of approximately $48,401,000 as of June 30, 2014. These NOLs expire on various dates through 2034. | |||||||||
The utilization of the NOLs may be limited under Section 382 of the Internal Revenue Code. | |||||||||
The Company’s deferred tax assets for the years ended June 30, 2014 and 2013 are estimated as follows: | |||||||||
2014 | 2013 | ||||||||
NOLs - noncurrent | $ | 18,392,000 | $ | 17,479,000 | |||||
Stock-based compensation - current | 4,832,000 | 4,684,000 | |||||||
Property and equipment - noncurrent | 741,000 | - | |||||||
Deferred compensation - noncurrent | 1,036,000 | 683,000 | |||||||
25,001,000 | 22,846,000 | ||||||||
Valuation allowance | (25,001,000 | ) | (22,846,000 | ) | |||||
Net deferred tax assets | $ | - | $ | - | |||||
The Company has provided a valuation allowance of 100% of its net deferred tax asset due to the uncertainty of generating future profits that would allow for the realization of such deferred tax assets. |
Note_12_401k_Plan
Note 12 - 401(k) Plan: | 12 Months Ended | |
Jun. 30, 2014 | ||
Compensation and Retirement Disclosure [Abstract] | ' | |
Pension and Other Postretirement Benefits Disclosure [Text Block] | ' | |
12 | 401(k) PLAN: | |
The Company has adopted the Bion Technologies, Inc. 401(k) Profit Sharing Plan and Trust (the “401(k) Plan”), a defined contribution retirement plan for the benefit of its employees. The 401(k) Plan is currently a salary deferral only plan and at this time the Company does not match employee contributions. The 401(k) is open to all employees over 21 years of age and no service requirement is necessary. |
Note_13_Commitments_And_Contin
Note 13 - Commitments And Contingencies: | 12 Months Ended | |
Jun. 30, 2014 | ||
Commitments and Contingencies Disclosure [Abstract] | ' | |
Commitments and Contingencies Disclosure [Text Block] | ' | |
13 | COMMITMENTS AND CONTINGENCIES: | |
Employment and consulting agreements: | ||
Smith has held the positions of Director, President and General Counsel of Company and its subsidiaries under various agreements and terms since March 2003. During July 2011, the Company entered into an extension agreement pursuant to which Smith continued to hold his current position in the Company through a date no later than December 31, 2012. Commencing January 1, 2012, Smith’s monthly salary was $20,000, which has been accrued and deferred. In addition, 90,000 shares of the Company’s common stock would be issued to Smith in two tranches of 45,000 shares on each of January 15, 2013 (issued) and 2014 (issued), respectively. The Company recorded expense of $240,300 for the year ended June 30, 2012, related to the future stock issuances as the bonus was fully vested at the grant date. As part of the extension agreement, Smith was also granted 200,000 options, which vested immediately, to purchase common shares of the Company at a price of $3.00 per share and which options expire on December 31, 2019. The Company recorded expense of $334,000 during the year ended June 30, 2012 as the options were fully vested at the grant date. Effective July 15, 2012, the Company entered into an extension agreement pursuant to which Smith will continue to hold his current positions in the Company through a date no later than June 30, 2014. Effective September 2012, Smith’s monthly salary became $21,000, until March 2014, at which time Smith agreed to a temporary reduction in monthly salary to $14,000 (which is currently being deferred). In addition, the extension provides that Smith will be issued 150,000 shares of the Company’s common stock in two tranches of 75,000 shares on each of January 15, 2014 (issued) and 2015 (to be issued), which shares vested immediately. The Company recorded expense of $292,500 for the year ended June 30, 2013, related to the future stock issuances as the bonus was fully vested at the grant date. As part of the extension agreement, Smith was also granted a bonus of $25,000 paid in warrants, which vested immediately, to purchase 250,000 shares of the Company’s common stock at a price of $2.10 per share and which warrants expire on December 31, 2018 and a contingent stock bonus of 100,000 shares payable on the date on which the Company’s stock price first reaches $10.00 per share (regardless of whether Smith is still providing services to the Company on such date). During September 2014, Smith agreed to continue his employment agreement through January 1, 2015 and also agreed to continue to defer his temporarily reduced salary of $14,000 per month until such date. | ||
Since March 31, 2005, the Company has had various agreements with Brightcap and/or Bassani, through which the services of Bassani are provided. On September 30, 2009 the Company entered into an extension agreement with Brightcap pursuant to which Bassani provided services to the Company through September 30, 2012 for $312,000 annually (currently deferred). The Board appointed Bassani as the Company's CEO effective May 13, 2011. On July 15, 2011, Bassani, Brightcap and the Company agreed to an extension/amendment of the existing agreement with Brightcap which provided that Bassani would continue to provide the services of CEO through June 30, 2013 and will continue to provide full-time services to the Company in other capacities through June 30, 2014 at a salary of $26,000 per month. In addition Bassani will be issued 300,000 shares of the Company’s common stock issuable in three tranches of 100,000 shares on each of January 15, 2015, 2016 and 2017, respectively. During the year ended June 30, 2012 the Company recorded expense of $795,000 related to the future stock issuances as the bonus was fully vested at the grant date. Bassani was also granted 725,000 options, which vested immediately, to purchase shares of the Company’s common stock at $3.00 per share which options expire on December 31, 2019. The Company recorded expense of $1,203,500 during the year ended June 30, 2012 as the options were fully vested at the grant date. Effective July 15, 2012, Bassani, Brightcap and the Company agreed to a further extension/amendment of the existing agreement with Brightcap which provides that Bassani will continue to provide the services of CEO through June 30, 2014. The extension provided that Bassani will continue to provide full-time services to the Company at a cash salary of $26,000 per month (which is currently being deferred) and Bassani will be issued 300,000 shares of the Company’s common stock issuable in two tranches of 150,000 shares on each of January 15, 2015 and 2016, respectively, which were immediately vested. The Company recorded expense of $585,000 for the year ended June 30, 2013, related to the future stock issuances as the bonus was fully vested at the grant date. As part of the extension agreement, Bassani was also granted a bonus of $5,000 paid in warrants, which vested immediately, to purchase 50,000 shares of the Company’s common stock at a price of $2.10 per share and which warrants expire on December 31, 2018. During September 2014, Bassani agreed to extend his employment agreement until January 1, 2015 and that previously issued and expensed share grants of 100,000 and 150,000 shares, that were to be issued on January 15, 2015, would be deferred until January 15, 2016. | ||
On May 5, 2013, the Board of Directors approved agreements with Bassani and Smith, with effective dates of May 15, 2013, in which Bassani and Smith have agreed to continue to defer their respective cash compensation through April 30, 2014 (unless the Board of Directors elects to re-commence cash payment on an earlier date) and to extend the due date of their respective deferred cash compensation until January 15, 2015 on the terms set forth in Note 7. In May 2014, Bassani and Smith have agreed to continue to defer their respective cash compensation through July 1, 2014. The Company has provided Bassani and Smith with convertible promissory notes which reflect all the terms of these agreements to which future accruals will be added as additional principal. As part of the agreements, Bassani and Smith have also forgiven any possible obligations that Bion may have owed each of them in relation to unused vacation time for periods (over 10 years) prior to June 30, 2012. In consideration of these agreements, Bassani and Smith: a) have been granted 50% ‘execution/exercise’ bonuses to be effective upon future exercise of outstanding (or subsequently acquired) options and warrants owned by Bassani and Smith (and their respective donees) and in relation to contingent stock bonuses; b) their warrants and options, if due to expire prior to December 31, 2018, have been extended to that date (with possible further extensions); and c) other modifications have been made. | ||
Effective January 1, 2011, the Company entered into an employment agreement with Edward Schafer pursuant to which for a period of three years, Schafer will provide senior management services to the Company on an approximately 75% full time basis, initially as Executive Vice Chairman and as a director. Compensation for Schafer’s services will initially be at an annual rate of $250,000, which will consist of $150,000 in cash compensation and $100,000 payable in the Company’s common stock. Commencing the month following the first calendar month-end after the Company has completed an equity financing in excess of $3,000,000 (net of commissions and other offering expenses), Schafer’s compensation shall be at an annual rate of $225,000, all of which shall be payable in cash. Effective July 15, 2012, the Company entered into a deferral/employment/ compensation agreement with Mr. Schafer pursuant to which Schafer continued to provide senior management services to the Company on an approximately 75% full time basis, initially as Executive Vice Chairman and as a director. Basic compensation for Schafer’s services remained unchanged and Schafer was issued 100,000 options to purchase shares of the Company’s common stock at $2.10 per share until December 31, 2018, which immediately vested and a contingent stock bonus of 25,000 shares payable on January 1 of the first year after the Company’s stock price first reaches $10.00 per share (regardless of whether Schafer is still providing services to the Company on such date). Due to the Company’s cash constraints, Schafer agreed to defer the cash portion of his compensation effective May 15, 2012. Mr. Schafer’s employment agreement expired on December 31, 2013. Mr. Schafer will continue to serve as the Company’s Executive Vice Chairman on a consulting basis with compensation to be determined by the Board from time-to-time. | ||
Effective September 18, 2006, the Company entered into a four-year employment agreement with Jeremy Rowland whereby Mr. Rowland assumed the position of Chief Operating Officer of Projects at an annual salary of $150,000. In June 2008, the employment agreement terms were extended through July 1, 2012. Mr. Rowland’s services were terminated effective July 31, 2013. Mr. Rowland currently provides consulting services for the Company on an ‘as needed’ basis. | ||
During January 2012, the Company approved an employment agreement contract extension effective January 1, 2012 with Craig Scott pursuant to which he continued to act as Vice President of Capital Markets and Shareholder Relations through December 31, 2012, at an annual salary of $144,000. In consideration for his extension agreement, Mr. Scott was granted 75,000 options to purchase shares of the Company’s common shares at $2.75 per share with an expiration date of December 31, 2016, 12,500 contingent stock options that will be issued if the Company’s stock price exceeds $10.00 and $20.00 per share, respectively, and an extension of the expiration dates all his existing warrants and options as of January 1, 2012 until December 31, 2016. Mr. Scott currently works for the Company on a month-to-month basis and beginning August 1, 2013 is receiving his compensation in common stock of the Company. | ||
Effective February 1, 2011, the Company entered into an employment agreement with James Morris, pursuant to which Mr. Morris will act as Chief Technology Officer of the Company through January 31, 2015 at an annual salary of $150,000 through July 1, 2011, and $180,000 thereafter. Mr. Morris’ services were terminated effective November 30, 2013. The Company has accrued expenses of $75,000 related to this termination, which is included in accrued liabilities as of June 30, 2014. The Company has also accrued deferred compensation and a deferred bonus and interest totalling approximately $186,000 for Mr. Morris as of June 30, 2014. The Company’s obligation to pay these sums to Mr. Morris is subject to the outcome of litigation initiated by Mr. Morris during May 2014 (see Litigation below). | ||
Effective September 27, 2011, the Company entered into an employment agreement with George Bloom, pursuant to which Mr. Bloom, the Company’s Chief Engineering Officer, will act as Vice President-Engineering of the Company through January 31, 2016 at an annual salary of $180,000. Mr. Bloom’s services were terminated effective November 30, 2013. The Company has accrued expense of $75,000 related to this termination, which is included in accrued liabilities as of June 30, 2014. The Company has also accrued deferred compensation and a deferred bonus totally approximately $120,000 for Mr. Bloom as of June 30, 2014. | ||
Contingent stock bonuses: | ||
In May 2005 the Company declared contingent deferred stock bonuses to its key employees and consultants. The stock bonuses are contingent upon the Company’s stock price exceeding $10.00 and $20.00 per share, respectively, and the grantees still being employed by or providing services to the Company at the time the target prices are reached. As of June 30, 2014, 227,500 and 65,000 of these contingent bonus shares, respectively, remain outstanding, to be issued when and if the Company’s stock price exceeds $10.00 and $20.00 per share, respectively. The Company has also granted 12,500 contingent stock options that will be issued if the Company’s stock price exceeds $10.00 and $20.00 per share, respectively, to one if its employees in consideration for an employment agreement extension effective January 1, 2012 | ||
Effective January 1, 2011 the Company declared a contingent stock bonus of 50,000 shares to Smith and effective July 15, 2012 the Company declared contingent stock bonuses of 100,000 and 25,000 shares to Smith and Schafer, respectively. The stock bonuses are contingent upon the Company’s stock price exceeding $10.00 and do not require that Smith or Schafer remain employed by the Company. | ||
Execution/exercise bonuses: | ||
As part of the agreements the Company entered into with Bassani and Smith (Note 7) effective May 15, 2013, whereby they agreed to continue to defer their cash compensation up to April 30, 2014, they were each granted the following: a) a 50% execution/exercise bonus which shall be applied upon the effective date of the notice of intent to exercise (for options and warrants) or issuance event, as applicable, of any currently outstanding and/or subsequently acquired options, warrants and/or contingent stock bonuses owned by each as follows: i) in the case of exercise by payment of cash, the bonus shall take the form of reduction of the exercise price; ii) in the case of cashless exercise, the bonus shall be applied to reduce the exercise price prior to the cashless exercise calculations; and iii) with regard to contingent stock bonuses, issuance shall be triggered upon the Company’s common stock reaching a closing price equal to 50% of currently specified price; and b) the right to extend the exercise period of all or part of the applicable options and warrants for up to five years (one year at a time) by annual payments of $.05 per option or warrant to the Company on or before a date during the three months prior to expiration of the exercise period at least three business days before the end of the expiration period. | ||
During the year ended June 30, 2014, the Company extended execution/exercise bonuses with the same terms as described above to Schafer and to one of the Company’s board members. | ||
Litigation: | ||
In May 2014 Mr. Morris, the Company’s former Chief Technology Officer, initiated litigation against the Company (Morris v Bion Environmental Technologies, Inc., 14-cv-02732-ADS-GRB, United States District Court, Eastern District of New York) related to his termination effective November 30, 2013. Mr. Morris seeks payment of severance pay (up to $90,000) plus certain previously accrued obligations totaling approximately $87,216 plus accrued interest (which sums have been accrued as of June 30, 2014, despite the fact that the Company is disputing the obligations) and attorney’s fees and re-instatement of 300,000 options to purchase the Company’s common stock at $2.00 to $3.00 per share until December 31, 2015. The Company disputes each such claim by Mr. Morris in the litigation and is defending the lawsuit which is in the early discovery stage. The Company is incurring attorney’s fees (and related costs) in the context of its defense. The Company does not believe that this litigation will have a material adverse effect on the Company. | ||
On September 25, 2014, Pennvest exercised its right to declare the Pennvest Loan in default and has accelerated the Pennvest Loan and has demanded that PA-1 pay $8,137,117 (principal, interest plus late charges) on or before October 24, 2014. During August 2012, the Company provided Pennvest (and the PADEP) with data demonstrating that the Kreider 1 system met the ‘technology guaranty’ standards which were incorporated in the Pennvest financing documents and, as a result, the Pennvest Loan is now solely an obligation of PA-1. No litigation has commenced related to this matter but such litigation is likely if negotiations do not produce a resolution (Note 1 and Note 6). | ||
The Company currently is not involved in any other material litigation. |
Note_14_Subsequent_Events
Note 14 - Subsequent Events: | 12 Months Ended | |
Jun. 30, 2014 | ||
Subsequent Events [Abstract] | ' | |
Subsequent Events [Text Block] | ' | |
14 | SUBSEQUENT EVENTS: | |
The Company has evaluated events that occurred subsequent to June 30, 2014 for recognition and disclosure in the financial statements and notes to the financial statements. | ||
From July 1, 2014 through September 24, 2014 the Company has issued 4,496 shares of the Company’s common shares to an employee and a consultant valued at approximately $4,600. | ||
From July 1, 2014 through September 24, 2014 the Company issued 40,000 shares of the Company’s restricted common stock upon receipt of its subscription receivable of $30,000. | ||
From July 1, 2014 through September 24, 2014 the Company sold 35,000 shares of the Company’s restricted common stock at $0.75 per share for total proceeds of $26,250. | ||
From July 1, 2014 through September 24, 2014 the Company issued 130,953 units (each unit consisting of one share of the Company’s stock and one warrant) for the conversion of $110,000 of convertible notes payable – affiliates at $0.84 per unit. |
Accounting_Policies_by_Policy_
Accounting Policies, by Policy (Policies) | 12 Months Ended | |
Jun. 30, 2014 | ||
Accounting Policies [Abstract] | ' | |
Consolidation, Policy [Policy Text Block] | ' | |
2 | SIGNIFICANT ACCOUNTING POLICIES | |
Principles of consolidation: | ||
The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Bion Integrated Projects Group, Inc. (“Projects Group”), Bion Technologies, Inc., BionSoil, Inc., Bion Services, PA-1, and Bion PA 2 LLC; and its 58.9% owned subsidiary, Centerpoint Corporation (“Centerpoint”). All significant intercompany accounts and transactions have been eliminated in consolidation. | ||
Cash and Cash Equivalents, Policy [Policy Text Block] | ' | |
The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash. | ||
Property, Plant and Equipment, Policy [Policy Text Block] | ' | |
Property and equipment are stated at cost and are depreciated, when placed into service, using the straight-line method over the estimated useful lives of the related assets, generally three to twenty years. The Company capitalizes all direct costs and all indirect incrementally identifiable costs related to the design and construction of its Integrated Projects. The Company reviews its property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. An impairment loss would be recognized based on the amount by which the carrying value of the assets or asset group exceeds its estimated fair value, and is recognized as a loss from operations. | ||
Derivatives, Policy [Policy Text Block] | ' | |
Pursuant to Accounting Standards Codification (“ASC”) Topic 815 “Derivatives and Hedging” (“Topic 815”), the Company reviews all financial instruments for the existence of features which may require fair value accounting and a related mark-to-market adjustment at each reporting period end. | ||
Once determined, the Company assesses these instruments as derivative assets or liabilities. The fair value of these instruments is adjusted to reflect the fair value at each reporting period end, with any increase or decrease in the fair value being recorded in results of operations as an adjustment to fair value of derivatives. | ||
Equity Issuances Warrants Policy [Policy Text Block] | 'The Company has issued warrants to purchase common shares of the Company. Warrants are valued using a fair value based method, whereby the fair value of the warrant is determined at the warrant issue date using a market-based option valuation model based on factors including an evaluation of the Company’s value as of the date of the issuance, consideration of the Company’s limited liquid resources and business prospects, the market price of the Company’s stock in its mostly inactive public market and the historical valuations and purchases of the Company’s warrants. When warrants are issued in combination with debt or equity securities, the warrants are valued and accounted for based on the relative fair value of the warrants in relation to the total value assigned to the debt or equity securities and warrants combined. | |
Concentration Risk, Credit Risk, Policy [Policy Text Block] | ' | |
The Company's financial instruments that are exposed to concentrations of credit risk consist of cash. The Company's cash is in demand deposit accounts placed with federally insured financial institutions and selected brokerage accounts. Such deposit accounts at times may exceed federally insured limits. The Company has not experienced any losses on such accounts. | ||
Minority Interest Policy [Policy Text Block] | 'In accordance with ASC 810, “Consolidation”, the Company separately classifies noncontrolling interests within the equity section of the consolidated balance sheets and separately reports the amounts attributable to controlling and noncontrolling interests in the consolidated statements of operations. In addition the noncontrolling interest continues to be attributed its share of losses even if that attribution results in a deficit noncontrolling interest balance. | |
Fair Value Measurement, Policy [Policy Text Block] | ' | |
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date in the principal or most advantageous market. The Company uses a fair value hierarchy that has three levels of inputs, both observable and unobservable, with use of the lowest possible level of input to determine fair value. | ||
Level 1 – quoted prices (unadjusted) in active markets for identical assets or liabilities; | ||
Level 2 – observable inputs other than Level 1, quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, and model-derived prices whose inputs are observable or whose significant value drivers are observable; and | ||
Level 3 – assets and liabilities whose significant value drivers are unobservable. | ||
Observable inputs are based on market data obtained from independent sources, while unobservable inputs are based on the Company’s market assumptions. Unobservable inputs require significant management judgment or estimation. In some cases, the inputs used to measure an asset or liability may fall into different levels of the fair value hierarchy. In those instances, the fair value measurement is required to be classified using the lowest level of input that is significant to the fair value measurement. Such determination requires significant management judgment. | ||
The fair value of cash and accounts payable approximates their carrying amounts due to their short-term maturities. The fair value of the loan payable approximates its carrying amount as it bears interest at rates commensurate with market rates. The fair value of the redeemable preferred stock approximates its carrying value due to the dividends accrued on the preferred stock which are reflected as part of the redemption value. The fair value of deferred compensation and loans payable – affiliates are not practicable to estimate due to the related party nature of the underlying transactions. | ||
As of June 30, 2014, property and equipment was measured at estimated fair value on a non-recurring basis using level 3 inputs, which resulted in impairment (Note 3). | ||
Revenue Recognition, Policy [Policy Text Block] | ' | |
Revenues are generated from the sale of nutrient reduction credits. The Company recognizes revenue from the sale of nutrient credits when there is persuasive evidence that an arrangement exists, when title has passed, the price is fixed or determinable, and collection is reasonably assured. | ||
The Company expects that technology license fees will be generated from the licensing of Bion’s integrated system. The Company anticipates that it will charge its customers a non-refundable up-front technology license fee, which will be recognized over the estimated life of the customer relationship. In addition, any on-going technology license fees will be recognized as earned based upon the performance requirements of the agreement. Annual waste treatment fees will be recognized upon receipt. Revenues, if any, from the Company’s interest in Integrated Projects will be recognized when the entity in which the Integrated Project has been developed recognizes such revenue. | ||
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] | ' | |
The Company recognizes the cost of employee services received in exchange for an award of equity instruments in the financial statements and the cost is measured based on the grant date fair value of the award. The stock option compensation expense is recognized over the period during which an employee is required to provide service in exchange for the award (the requisite service period). The Company utilizes the Black-Scholes option-pricing model to determine fair value. Key assumptions of the Black-Scholes option-pricing model include applicable volatility rates, risk-free interest rates and the instrument’s expected remaining life. These assumptions require significant management judgment. | ||
The Company has issued non-employee options that include service conditions and have graded vesting schedules. Generally for these arrangements, the measurement date of the services occurs when the options vest. Recognition of compensation cost for reporting periods prior to the measurement date is based on the then current fair value of the options. Fair value of the options is determined using a Black-Scholes option-pricing model. Any subsequent changes in fair value will be recorded on the measurement date. Compensation cost in connection with options that are not fully vested is being recognized on a straight-line basis over the requisite service period for the entire award. | ||
Income Tax, Policy [Policy Text Block] | ' | |
The Company recognizes deferred tax assets and liabilities for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their tax bases, as well as net operating losses. | ||
Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets or liabilities of a change in tax rates is recognized in the period in which the tax change occurs. A valuation allowance is provided to reduce the deferred tax assets by 100%, since the Company believes that at this time it is more likely than not that the deferred tax asset will not be realized. | ||
The Company is no longer subject to U.S. federal and state tax examinations for fiscal years before 2009. Management does not believe there will be any material changes in the Company’s unrecognized tax positions over the next 12 months. | ||
The Company's policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. As of June 30, 2014, there were no penalties or accrued interest amounts associated with any unrecognized tax benefits, nor was any interest expense recognized during the years ended June 30, 2014 and 2013. | ||
Earnings Per Share, Policy [Policy Text Block] | ' | |
Basic loss per share amounts are calculated using the weighted average number of shares of common stock outstanding during the period. Diluted loss per share assumes the conversion, exercise or issuance of all potential common stock instruments, such as options or warrants, unless the effect is to reduce the loss per share. During the years ended June 30, 2014 and 2013, the basic and diluted loss per share was the same, as the impact of potential dilutive common shares was anti-dilutive. | ||
Use of Estimates, Policy [Policy Text Block] | ' | |
In preparing the Company’s consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. | ||
New Accounting Pronouncements, Policy [Policy Text Block] | ' | |
The Company has evaluated all newly issued accounting pronouncements and believes such pronouncements do not have a material effect on the Company’s financial statements. |
Note_2_Significant_Accounting_1
Note 2 - Significant Accounting Policies (Tables) | 12 Months Ended | ||||||||
Jun. 30, 2014 | |||||||||
Accounting Policies [Abstract] | ' | ||||||||
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] | ' | ||||||||
June 30, | June 30, | ||||||||
2014 | 2013 | ||||||||
Warrants | 7,622,653 | 7,126,235 | |||||||
Options | 4,258,870 | 5,261,145 | |||||||
Convertible debt | 2,820,157 | 1,196,182 | |||||||
Convertible preferred stock | 13,000 | 12,000 | |||||||
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] | ' | ||||||||
Year ended | Year ended | ||||||||
June 30, | June 30, | ||||||||
2014 | 2013 | ||||||||
Shares issued – beginning of period | 17,673,983 | 16,814,103 | |||||||
Shares held by subsidiaries (Note 8) | (704,309 | ) | (704,309 | ) | |||||
Shares outstanding – beginning of period | 16,969,674 | 16,109,794 | |||||||
Weighted average shares for fully vested stock bonuses (Note 8) | 840,000 | 821,507 | |||||||
Weighted average shares issued during the period | 826,690 | 384,135 | |||||||
Basic weighted average shares – end of period | 18,636,364 | 17,315,436 |
Note_3_Property_and_Equipment_
Note 3 - Property and Equipment: (Tables) | 12 Months Ended | ||||||||
Jun. 30, 2014 | |||||||||
Property, Plant and Equipment [Abstract] | ' | ||||||||
Property, Plant and Equipment [Table Text Block] | ' | ||||||||
June 30, | June 30, | ||||||||
2014 | 2013 | ||||||||
Machinery and equipment | $ | 4,111,001 | $ | 5,432,947 | |||||
Buildings and structures | 1,947,701 | 2,574,010 | |||||||
Leasehold improvements | - | 31,336 | |||||||
Furniture | - | 28,932 | |||||||
Computers and office equipment | 183,809 | 243,058 | |||||||
6,242,511 | 8,310,283 | ||||||||
Less accumulated depreciation | (1,891,358 | ) | (979,263 | ) | |||||
$ | 4,351,153 | $ | 7,331,020 |
Note_8_Stockholders_Equity_Tab
Note 8 - Stockholders' Equity: (Tables) | 12 Months Ended | ||||||||||||||||
Jun. 30, 2014 | |||||||||||||||||
Stockholders' Equity Note [Abstract] | ' | ||||||||||||||||
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] | ' | ||||||||||||||||
Weighted | Range, | Weighted | Range, | ||||||||||||||
average, | 30-Jun-14 | average, | 30-Jun-13 | ||||||||||||||
30-Jun-14 | 30-Jun-13 | ||||||||||||||||
Volatility | 54 | % | 49%-65 | % | 66 | % | 60%-68 | % | |||||||||
Dividend yield | - | - | - | - | |||||||||||||
Risk-free interest rate | 0.95 | % | 0.59%-1.69 | % | 0.32 | % | 0.31%-0.34 | % | |||||||||
Expected term (years) | 3.29 | 2.63-4.67 | 3.05 | 2.66-3.25 | |||||||||||||
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] | ' | ||||||||||||||||
Options | Weighted- | Weighted- | Aggregate | ||||||||||||||
Average | Average | Intrinsic | |||||||||||||||
Exercise | Remaining | Value | |||||||||||||||
Price | Contractual | ||||||||||||||||
Life | |||||||||||||||||
Outstanding at July 1, 2012 | 5,111,145 | $ | 2.86 | 4.6 | $ | - | |||||||||||
Granted | 150,000 | 2.1 | |||||||||||||||
Exercised | - | - | |||||||||||||||
Forfeited | - | - | |||||||||||||||
Expired | - | - | |||||||||||||||
Outstanding at June 30, 2013 | 5,261,145 | 2.84 | 4 | - | |||||||||||||
Granted | 97,725 | 1.35 | |||||||||||||||
Exercised | - | - | |||||||||||||||
Forfeited | (200,000 | ) | 3 | ||||||||||||||
Expired | (900,000 | ) | 2.84 | ||||||||||||||
Outstanding at June 30, 2014 | 4,258,870 | $ | 2.81 | 3.2 | $ | 10,500 | |||||||||||
Exercisable at June 30, 2014 | 4,258,870 | $ | 2.81 | 3.2 | $ | 10,500 | |||||||||||
Schedule of Nonvested Share Activity [Table Text Block] | ' | ||||||||||||||||
Options | Weighted Average | ||||||||||||||||
Grant-Date Fair | |||||||||||||||||
Value | |||||||||||||||||
Nonvested at July 1, 2013 | 325,000 | $ | 1.86 | ||||||||||||||
Granted | 97,725 | 0.58 | |||||||||||||||
Vested | (222,725 | ) | (1.08 | ) | |||||||||||||
Forfeited | (200,000 | ) | (2.10 | ) | |||||||||||||
Nonvested at June 30, 2014 | - | $ | - | ||||||||||||||
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block] | ' | ||||||||||||||||
Year ended | Year ended | ||||||||||||||||
June 30, | June 30, | ||||||||||||||||
2014 | 2013 | ||||||||||||||||
General and administrative: | |||||||||||||||||
Fair value of stock/warrant bonuses expensed | $ | - | $ | 1,159,575 | |||||||||||||
Fair value of stock issued to an employee | 94,998 | 99,996 | |||||||||||||||
Change in fair value from modification of option terms | 307,638 | 2,496,700 | |||||||||||||||
Fair value of stock options (credited)/expensed | (87,517 | ) | 416,804 | ||||||||||||||
Total | $ | 315,119 | $ | 4,173,075 | |||||||||||||
Research and development: | |||||||||||||||||
Fair value of stock options (credited)/expensed | $ | (116,739 | ) | $ | 38,276 | ||||||||||||
Total | $ | (116,739 | ) | $ | 38,276 |
Note_11_Income_Taxes_Tables
Note 11 - Income Taxes: (Tables) | 12 Months Ended | ||||||||
Jun. 30, 2014 | |||||||||
Income Tax Disclosure [Abstract] | ' | ||||||||
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] | ' | ||||||||
2014 | 2013 | ||||||||
Expected income tax benefit at statutory rate | $ | (1,959,000 | ) | $ | (2,805,000 | ) | |||
State taxes, net of federal benefit | (177,000 | ) | (252,000 | ) | |||||
Permanent differences and other | (19,000 | ) | (28,000 | ) | |||||
Expiration of NOLs | - | - | |||||||
Change in valuation allowance | 2,155,000 | 3,085,000 | |||||||
Income tax benefit | $ | - | $ | - | |||||
Schedule of Deferred Tax Assets and Liabilities [Table Text Block] | ' | ||||||||
2014 | 2013 | ||||||||
NOLs - noncurrent | $ | 18,392,000 | $ | 17,479,000 | |||||
Stock-based compensation - current | 4,832,000 | 4,684,000 | |||||||
Property and equipment - noncurrent | 741,000 | - | |||||||
Deferred compensation - noncurrent | 1,036,000 | 683,000 | |||||||
25,001,000 | 22,846,000 | ||||||||
Valuation allowance | (25,001,000 | ) | (22,846,000 | ) | |||||
Net deferred tax assets | $ | - | $ | - |
Note_1_Organization_Nature_of_1
Note 1 - Organization, Nature of Business, Going Concern and Management's Plans: (Details) (USD $) | 12 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended | ||||||||||||||||
Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2012 | Aug. 12, 2010 | Jun. 30, 2014 | Jun. 30, 2014 | Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2014 | Jun. 30, 2014 | Jun. 30, 2014 | Jun. 30, 2014 | Jun. 30, 2014 | Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2014 | Jun. 30, 2014 | Sep. 25, 2014 | Jun. 30, 2014 | Jun. 30, 2014 | |
CEO and Shareholder [Member] | CEO and Shareholder [Member] | Subscriptions Receivable [Member] | Subscriptions Receivable [Member] | Restricted Stock at $1.25 [Member] | Restricted Stock [Member] | Restricted Stock [Member] | Restricted Stock [Member] | Restricted Stock [Member] | Restricted Stock [Member] | Restricted Stock [Member] | Property, Plant And Equipment of PA-1 [Member] | Property, Plant And Equipment of PA-1 [Member] | Subsequent Event [Member] | Scenario, Forecast [Member] | Scenario, Forecast [Member] | |||||
December Notes [Member] | December Notes [Member] | Restricted Stock [Member] | Restricted Stock [Member] | Restricted Stock [Member] | Net Proceeds [Member] | Net Proceeds [Member] | Subscription Agreement [Member] | Additional Issuance When Stock Sold at Lower than 1.25 Per Share [Member] | PA-1 [Member] | PA-1 [Member] | PA-1 [Member] | Minimum [Member] | Maximum [Member] | |||||||
Maximum [Member] | Subscription Agreement [Member] | |||||||||||||||||||
Note 1 - Organization, Nature of Business, Going Concern and Management's Plans: (Details) [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Construction Loan | ' | ' | ' | $7,800,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Impairment of Long-Lived Assets Held-for-use | 2,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 2,000,000 | 2,000,000 | ' | ' | ' |
Property, Plant and Equipment, Gross | 6,242,511 | 8,310,283 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 4,349,482 | 4,349,482 | ' | ' | ' |
Debt Instrument, Debt Default, Amount | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 8,137,117 | ' | ' |
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | -5,761,989 | -8,249,895 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Working Capital | -11,784,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | -7,456,060 | -3,401,615 | -774,180 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Proceeds from Issuance or Sale of Equity | 944,400 | 1,330,499 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Stock Issued During Period, Shares, New Issues (in Shares) | ' | ' | ' | ' | ' | ' | 40,000 | ' | 400,000 | ' | ' | 592,534 | ' | 400,000 | 216,000 | ' | ' | ' | ' | ' |
Stock Issued During Period, Price Per Share (in Dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $0.75 | ' | $1.25 | ' | ' | ' | ' | ' | ' |
Proceeds from Issuance of Common Stock | 944,400 | 270,000 | ' | ' | ' | ' | ' | ' | ' | 467,575 | 500,000 | 474,400 | ' | 500,000 | ' | ' | ' | ' | ' | ' |
Stock Issued During Period, Value, New Issues | 967,575 | 292,375 | ' | ' | ' | ' | 30,000 | 25,000 | ' | ' | ' | ' | 266,667 | ' | 292,375 | ' | ' | ' | ' | ' |
Related Party Transaction, Amounts of Transaction | ' | ' | ' | ' | 75,000 | 75,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Proceeds from Related Party Debt | 185,149 | 295,000 | ' | ' | ' | 135,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Capital Required for Capital Adequacy | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $2,500,000 | $50,000,000 |
Note_2_Significant_Accounting_2
Note 2 - Significant Accounting Policies (Details) (USD $) | 12 Months Ended |
Jun. 30, 2014 | |
Note 2 - Significant Accounting Policies (Details) [Line Items] | ' |
Deferred Tax Assets Reduction Percentage | 100.00% |
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | $0 |
Minimum [Member] | ' |
Note 2 - Significant Accounting Policies (Details) [Line Items] | ' |
Property, Plant and Equipment, Useful Life | '3 years |
Maximum [Member] | ' |
Note 2 - Significant Accounting Policies (Details) [Line Items] | ' |
Property, Plant and Equipment, Useful Life | '20 years |
Centerpoint [Member] | ' |
Note 2 - Significant Accounting Policies (Details) [Line Items] | ' |
Equity Method Investment, Ownership Percentage | 58.90% |
Note_2_Significant_Accounting_3
Note 2 - Significant Accounting Policies (Details) - Antidilutive Securities | 12 Months Ended | |
Jun. 30, 2014 | Jun. 30, 2013 | |
Warrant [Member] | ' | ' |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ' | ' |
Antidilutive Securities | 7,622,653 | 7,126,235 |
Equity Option [Member] | ' | ' |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ' | ' |
Antidilutive Securities | 4,258,870 | 5,261,145 |
Convertible Debt Securities [Member] | ' | ' |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ' | ' |
Antidilutive Securities | 2,820,157 | 1,196,182 |
Convertible Preferred Stock, Antidilutive Securities [Member] | ' | ' |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ' | ' |
Antidilutive Securities | 13,000 | 12,000 |
Note_2_Significant_Accounting_4
Note 2 - Significant Accounting Policies (Details) - Earnings Per Share, Basic and Diluted | 12 Months Ended | ||
Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2014 | |
Earnings Per Share, Basic and Diluted [Abstract] | ' | ' | ' |
Shares issued b beginning of period | 17,673,983 | 16,814,103 | 19,576,619 |
Shares held by subsidiaries (Note 8) | -704,309 | -704,309 | ' |
Shares outstanding b beginning of period | 16,969,674 | 16,109,794 | 18,872,310 |
Weighted average shares for fully vested stock bonuses (Note 8) | 840,000 | 821,507 | ' |
Weighted average shares issued during the period | 826,690 | 384,135 | ' |
Basic weighted average shares b end of period | 18,636,364 | 17,315,436 | ' |
Note_3_Property_and_Equipment_1
Note 3 - Property and Equipment: (Details) (USD $) | 12 Months Ended | |
Jun. 30, 2014 | Jun. 30, 2013 | |
Property, Plant and Equipment [Abstract] | ' | ' |
Capitalized Costs for Kreider 1 | ' | $8,219,617 |
Depreciation | 978,798 | 905,871 |
Impairment of Long-Lived Assets Held-for-use | $2,000,000 | ' |
Note_3_Property_and_Equipment_2
Note 3 - Property and Equipment: (Details) - Property and Equipment (USD $) | Jun. 30, 2014 | Jun. 30, 2013 |
Property and Equipment [Abstract] | ' | ' |
Machinery and equipment | $4,111,001 | $5,432,947 |
Buildings and structures | 1,947,701 | 2,574,010 |
Leasehold improvements | ' | 31,336 |
Furniture | ' | 28,932 |
Computers and office equipment | 183,809 | 243,058 |
6,242,511 | 8,310,283 | |
Less accumulated depreciation | -1,891,358 | -979,263 |
$4,351,153 | $7,331,020 |
Note_4_Loans_Payable_Affiliate1
Note 4 - Loans Payable - Affiliates: (Details) (USD $) | 12 Months Ended | |
Jun. 30, 2014 | Jun. 30, 2013 | |
Note 4 - Loans Payable - Affiliates: (Details) [Line Items] | ' | ' |
Proceeds from Related Party Debt | $185,149 | $295,000 |
Chief Executive Officer [Member] | Loan [Member] | ' | ' |
Note 4 - Loans Payable - Affiliates: (Details) [Line Items] | ' | ' |
Proceeds from Related Party Debt | 200,000 | ' |
Related Party Transaction, Rate | 8.00% | ' |
Related Party Transaction, Expenses from Transactions with Related Party | 16,318 | 6,618 |
Chief Executive Officer [Member] | November Note [Member] | ' | ' |
Note 4 - Loans Payable - Affiliates: (Details) [Line Items] | ' | ' |
Proceeds from Related Party Debt | 19,000 | ' |
Related Party Transaction, Rate | 8.00% | ' |
Interest Expense, Related Party | 904 | ' |
Chief Executive Officer [Member] | December Notes [Member] | ' | ' |
Note 4 - Loans Payable - Affiliates: (Details) [Line Items] | ' | ' |
Proceeds from Related Party Debt | 60,000 | ' |
Chief Executive Officer [Member] | ' | ' |
Note 4 - Loans Payable - Affiliates: (Details) [Line Items] | ' | ' |
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $2.50 | ' |
CEO and Shareholder [Member] | December Notes [Member] | Maturity Date Extension [Member] | ' | ' |
Note 4 - Loans Payable - Affiliates: (Details) [Line Items] | ' | ' |
Interest Expense, Related Party | 10,500 | ' |
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares) | 105,000 | ' |
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $0.85 | ' |
CEO and Shareholder [Member] | December Notes [Member] | Maximum [Member] | ' | ' |
Note 4 - Loans Payable - Affiliates: (Details) [Line Items] | ' | ' |
Related Party Transaction, Amounts of Transaction | 75,000 | ' |
CEO and Shareholder [Member] | December Notes [Member] | ' | ' |
Note 4 - Loans Payable - Affiliates: (Details) [Line Items] | ' | ' |
Proceeds from Related Party Debt | 135,000 | ' |
Related Party Transaction, Rate | 8.00% | ' |
Interest Expense, Related Party | 5,211 | ' |
Related Party Transaction, Amounts of Transaction | 75,000 | ' |
Related Party Transaction, Extension Period | '3 months | ' |
Related Party Transaction, Number of Additional Extensions | 3 | ' |
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares) | 18,750 | ' |
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $0.85 | ' |
Class of Warrant or Right Issued (in Shares) | 105,000 | ' |
Majority Shareholder [Member] | December Notes [Member] | ' | ' |
Note 4 - Loans Payable - Affiliates: (Details) [Line Items] | ' | ' |
Proceeds from Related Party Debt | 75,000 | ' |
President [Member] | Working Capital Loan [Member] | ' | ' |
Note 4 - Loans Payable - Affiliates: (Details) [Line Items] | ' | ' |
Proceeds from Related Party Debt | $10,000 | ' |
President [Member] | ' | ' |
Note 4 - Loans Payable - Affiliates: (Details) [Line Items] | ' | ' |
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $2.50 | ' |
Maximum [Member] | ' | ' |
Note 4 - Loans Payable - Affiliates: (Details) [Line Items] | ' | ' |
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $4.25 | ' |
Note_5_Deferred_Compensation_D
Note 5 - Deferred Compensation: (Details) (USD $) | Jun. 30, 2014 | Jun. 30, 2013 | Jul. 31, 2014 | Sep. 23, 2014 | Jun. 30, 2014 | Jun. 30, 2014 | Jun. 30, 2014 |
Subsequent Event [Member] | Subsequent Event [Member] | Accrued Interest at 10% per annum and Convertible at $1.50 per share [Member] | Executive Vice Chairman and Four Other Key Employees [Member] | Chief Executive Officer [Member] | |||
Executive Vice Chairman and Four Other Key Employees [Member] | Chief Executive Officer [Member] | ||||||
Note 5 - Deferred Compensation: (Details) [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Deferred Compensation Liability, Current | $716,734 | $520,583 | ' | ' | ' | $485,734 | ' |
Deferred Compensation Arrangement with Individual, Fair Value of Shares Issued | ' | ' | 984 | ' | ' | ' | ' |
Deferred Compensation Arrangement with Individual, Shares Issued (in Shares) | ' | ' | 807 | ' | ' | ' | ' |
Deferred Compensation Arrangement with Individual, Recorded Liability | ' | ' | ' | ' | ' | ' | 231,000 |
Accrued Interest on Deferred Compensation | ' | ' | ' | ' | ' | ' | $66,000 |
Interest Rate on Deferred Compensation | ' | ' | ' | ' | 10.00% | ' | ' |
Debt Instrument, Convertible, Conversion Price (in Dollars per share) | ' | ' | ' | $0.84 | $1.50 | ' | ' |
Note_6_Loan_Payable_Details
Note 6 - Loan Payable: (Details) (USD $) | 12 Months Ended | 1 Months Ended | 12 Months Ended | 12 Months Ended | |||||||
Jun. 30, 2014 | Jun. 30, 2013 | Aug. 12, 2010 | Jun. 30, 2014 | Jun. 30, 2014 | Sep. 25, 2014 | Jun. 30, 2014 | Jun. 30, 2014 | Jun. 30, 2014 | Jun. 30, 2014 | Jun. 30, 2013 | |
Property, Plant And Equipment of PA-1 [Member] | Property, Plant And Equipment of PA-1 [Member] | Subsequent Event [Member] | Interest Only Payments, Number of Years [Member] | Years 1 through 5 [Member] | Years 6 through Maturity [Member] | Pennvest Loan [Member] | Pennvest Loan [Member] | ||||
PA-1 [Member] | PA-1 [Member] | PA-1 [Member] | Pennvest Loan [Member] | Pennvest Loan [Member] | Pennvest Loan [Member] | ||||||
Note 6 - Loan Payable: (Details) [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Construction Loan | ' | ' | $7,800,000 | ' | ' | ' | ' | ' | ' | $7,754,000 | ' |
Line of Credit Facility, Maximum Borrowing Capacity | ' | ' | ' | ' | ' | ' | ' | ' | ' | 7,754,000 | ' |
Term Loan Payment Term | ' | ' | ' | ' | ' | ' | '3 years | ' | ' | ' | ' |
Debt Instrument, Interest Rate During Period | ' | ' | ' | ' | ' | ' | ' | 2.55% | 3.18% | ' | ' |
Repayments of Long-term Debt | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 574,000 |
Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months | ' | ' | ' | ' | ' | ' | ' | ' | ' | 704,000 | ' |
Long-term Debt, Maturities, Repayments of Principal in Year Two | ' | ' | ' | ' | ' | ' | ' | ' | ' | 723,000 | ' |
Long-term Debt, Maturities, Repayments of Principal in Year Three | ' | ' | ' | ' | ' | ' | ' | ' | ' | 741,000 | ' |
Long-term Debt, Maturities, Repayments of Principal in Year Four | ' | ' | ' | ' | ' | ' | ' | ' | ' | 760,000 | ' |
Long-term Debt, Maturities, Repayments of Principal after Year Four | ' | ' | ' | ' | ' | ' | ' | ' | ' | 4,252,000 | ' |
Interest Expense, Debt | ' | ' | ' | ' | ' | ' | ' | ' | ' | 197,494 | 197,494 |
Interest Costs Capitalized | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 15,793 |
Impairment of Long-Lived Assets Held-for-use | 2,000,000 | ' | ' | 2,000,000 | 2,000,000 | ' | ' | ' | ' | ' | ' |
Property, Plant and Equipment, Gross | 6,242,511 | 8,310,283 | ' | 4,349,482 | 4,349,482 | ' | ' | ' | ' | ' | ' |
Debt Instrument, Debt Default, Amount | ' | ' | ' | ' | ' | $8,137,117 | ' | ' | ' | ' | ' |
Note_7_Convertible_Notes_Payab1
Note 7 - Convertible Notes Payable - Affiliates (Details) (USD $) | 12 Months Ended | |
Jun. 30, 2014 | Jun. 30, 2013 | |
Note 7 - Convertible Notes Payable - Affiliates (Details) [Line Items] | ' | ' |
Convertible Notes Payable, Noncurrent | ' | $1,316,478 |
Debt Instrument, Convertible, Beneficial Conversion Feature | 0 | ' |
CEO and President [Member] | Exercise Bonus [Member] | ' | ' |
Note 7 - Convertible Notes Payable - Affiliates (Details) [Line Items] | ' | ' |
Execution Bonus as a Percentage of Exercised Options and Warrants | 50.00% | ' |
CEO and President [Member] | Convertible Notes Payable [Member] | Maximum [Member] | ' | ' |
Note 7 - Convertible Notes Payable - Affiliates (Details) [Line Items] | ' | ' |
Debt Instrument, Convertible, Conversion Price (in Dollars per share) | $1.25 | ' |
CEO and President [Member] | Convertible Notes Payable [Member] | ' | ' |
Note 7 - Convertible Notes Payable - Affiliates (Details) [Line Items] | ' | ' |
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $2.50 | ' |
CEO and President [Member] | Minimum [Member] | ' | ' |
Note 7 - Convertible Notes Payable - Affiliates (Details) [Line Items] | ' | ' |
Unused Vacation Time | '10 years | ' |
CEO and President [Member] | ' | ' |
Note 7 - Convertible Notes Payable - Affiliates (Details) [Line Items] | ' | ' |
Number of Warrants Per Unit | 1 | ' |
Number of Shares Per Unit | 1 | ' |
President [Member] | Deferred Compensation [Member] | ' | ' |
Note 7 - Convertible Notes Payable - Affiliates (Details) [Line Items] | ' | ' |
Convertible Notes Payable, Noncurrent | 671,468 | ' |
President [Member] | Accrued Interest [Member] | ' | ' |
Note 7 - Convertible Notes Payable - Affiliates (Details) [Line Items] | ' | ' |
Convertible Notes Payable, Noncurrent | 70,589 | ' |
President [Member] | ' | ' |
Note 7 - Convertible Notes Payable - Affiliates (Details) [Line Items] | ' | ' |
Convertible Notes Payable, Noncurrent | 742,057 | ' |
Debt Instrument, Convertible, Conversion Price (in Dollars per share) | $0.75 | ' |
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $2.50 | ' |
Debt Conversion, Original Debt, Amount | 187,500 | ' |
Debt Conversion, Converted Instrument, Units Issued (in Shares) | 250,000 | ' |
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 250,000 | ' |
Debt Conversion, Converted Instrument, Warrants or Options Issued (in Shares) | 250,000 | ' |
Chief Executive Officer [Member] | Deferred Compensation [Member] | ' | ' |
Note 7 - Convertible Notes Payable - Affiliates (Details) [Line Items] | ' | ' |
Convertible Notes Payable, Noncurrent | 878,000 | ' |
Chief Executive Officer [Member] | Accrued Interest [Member] | ' | ' |
Note 7 - Convertible Notes Payable - Affiliates (Details) [Line Items] | ' | ' |
Convertible Notes Payable, Noncurrent | 116,445 | ' |
Chief Executive Officer [Member] | ' | ' |
Note 7 - Convertible Notes Payable - Affiliates (Details) [Line Items] | ' | ' |
Convertible Notes Payable, Noncurrent | 994,445 | ' |
Debt Instrument, Convertible, Conversion Price (in Dollars per share) | $0.84 | ' |
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $2.50 | ' |
Debt Conversion, Original Debt, Amount | $110,000 | ' |
Debt Conversion, Converted Instrument, Units Issued (in Shares) | 130,953 | ' |
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 130,953 | ' |
Debt Conversion, Converted Instrument, Warrants or Options Issued (in Shares) | 130,953 | ' |
Convertible Notes Payable [Member] | ' | ' |
Note 7 - Convertible Notes Payable - Affiliates (Details) [Line Items] | ' | ' |
Debt Instrument, Interest Rate, Effective Percentage | 8.00% | ' |
Maximum [Member] | ' | ' |
Note 7 - Convertible Notes Payable - Affiliates (Details) [Line Items] | ' | ' |
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $4.25 | ' |
Minimum [Member] | ' | ' |
Note 7 - Convertible Notes Payable - Affiliates (Details) [Line Items] | ' | ' |
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $0.75 | ' |
Sale of Stock, Price Per Share (in Dollars per share) | $0.75 | ' |
Note_8_Stockholders_Equity_Det
Note 8 - Stockholders' Equity: (Details) (USD $) | 12 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 0 Months Ended | 12 Months Ended | 12 Months Ended | 0 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 0 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 23 Months Ended | 12 Months Ended | 12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2012 | Jun. 30, 2014 | Jun. 30, 2014 | Jun. 30, 2014 | Jun. 30, 2014 | Jun. 30, 2014 | Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2014 | Jun. 30, 2014 | Jun. 30, 2014 | Jun. 30, 2014 | Jun. 30, 2013 | Jul. 01, 2012 | Jun. 30, 2014 | Jun. 30, 2013 | Jul. 01, 2012 | Jun. 30, 2012 | Jun. 30, 2012 | Jun. 30, 2013 | Jul. 01, 2012 | Jun. 30, 2013 | Jun. 30, 2014 | Feb. 15, 2013 | Jul. 01, 2012 | Jun. 30, 2012 | Jun. 30, 2012 | Jun. 30, 2013 | Jun. 30, 2014 | Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2013 | Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2013 | Jun. 30, 2013 | Jun. 30, 2014 | Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2013 | Jun. 30, 2013 | Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2014 | Jun. 30, 2014 | Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2013 | Jun. 30, 2013 | Jun. 30, 2013 | Jun. 30, 2013 | Jun. 30, 2014 | Jun. 30, 2014 | Jun. 30, 2014 | Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2014 | Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2013 | Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2013 | Jun. 30, 2013 | Jun. 30, 2012 | Jun. 30, 2013 | Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2013 | Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2013 | |
Employees and Consultants [Member] | Employees and Consultants [Member] | Employees and Consultants [Member] | President [Member] | Chief Executive Officer [Member] | CEO and President [Member] | CEO and President [Member] | CEO and President [Member] | Former Employee [Member] | Executive Vice Chairman and Board Member [Member] | Subscriptions Receivable [Member] | Subscriptions Receivable [Member] | Series B Preferred Stock [Member] | Series B Preferred Stock [Member] | Series B Preferred Stock [Member] | Series B Preferred Stock [Member] | Series C Preferred Stock [Member] | Series C Preferred Stock [Member] | Series C Preferred Stock [Member] | Series C Preferred Stock [Member] | Series C Preferred Stock [Member] | Series C Preferred Stock [Member] | Series C Preferred Stock [Member] | Series C Preferred Stock [Member] | Series C Preferred Stock [Member] | Restricted Common Stock [Member] | The 2013 Units [Member] | Restricted Stock [Member] | Restricted Stock [Member] | B Unit 2012 [Member] | Warrants Issued Relating to Consultant Agreement [Member] | Warrants Issued Relating to Consultant Agreement [Member] | Warrants Issued Relating to Consultant Agreement [Member] | Warrants Issued Relating to Consultant Agreement [Member] | Warrants Issued Relating to Consultant Agreement [Member] | Warrants Issued Relating to Consultant Agreement [Member] | Restricted Stock [Member] | Restricted Stock [Member] | Restricted Stock [Member] | Restricted Stock [Member] | Restricted Stock [Member] | B Unit 2012 [Member] | The 2013 Units [Member] | Subscriptions Receivable [Member] | Subscriptions Receivable [Member] | Subscriptions Receivable [Member] | Exercise Bonus [Member] | Exercise Bonus [Member] | Exercise Bonus [Member] | Exercise Bonus [Member] | Expired [Member] | Employee Stock Option [Member] | Employee Stock Option [Member] | Employee Stock Option [Member] | Tranch 1 [Member] | Tranch 1 [Member] | Tranch 2 [Member] | Tranch 2 [Member] | Stock Issued for Accounts Payable [Member] | Stock Issued for Accounts Payable [Member] | Stock Issued for Accounts Payable [Member] | Subscription Agreement [Member] | Modification of Warrants [Member] | Minimum [Member] | Maximum [Member] | Warrant Issuances [Member] | Warrant Issuances [Member] | Warrant Issuances [Member] | Chief Executive Officer [Member] | President [Member] | President [Member] | President [Member] | Executive Vice Chairman [Member] | Executive Vice Chairman [Member] | Executive Vice Chairman [Member] | CEO and President [Member] | CEO and Shareholder [Member] | Officer [Member] | Contingent Consideration Classified as Equity [Member] | ||||
Minimum [Member] | Maximum [Member] | Exercise Bonus [Member] | Employee Stock Option [Member] | Employee Stock Option [Member] | Employee Stock Option [Member] | Restricted Stock [Member] | Restricted Stock [Member] | Number of Warrants Issued for Each 10 Shaes Received by Participating Series C Stockholders [Member] | Number of Shares Received by the Participating Series C Stockholders for Each Warrant Issued [Member] | Broker [Member] | Net Proceeds [Member] | Minimum [Member] | Minimum [Member] | Maximum [Member] | Maximum [Member] | Net Proceeds [Member] | Minimum [Member] | Maximum [Member] | CEO and President [Member] | CEO, President, and Executive Vice Chairman [Member] | Maximum [Member] | Chief Executive Officer [Member] | President [Member] | Chief Executive Officer [Member] | President [Member] | Minimum [Member] | Maximum [Member] | Chief Executive Officer [Member] | President [Member] | Contingent Consideration Classified as Equity [Member] | Contingent Consideration Classified as Equity [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||
Note 8 - Stockholders' Equity: (Details) [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Preferred Stock, Shares Outstanding | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 200 | 200 | 450 | ' | ' | ' | ' | 0 | 0 | ' | 300 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Preferred Stock, Par or Stated Value Per Share (in Dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $0.01 | $0.01 | $0.01 | ' | ' | ' | ' | $0.01 | $0.01 | ' | $0.01 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Preferred Stock, Redemption Price Per Share (in Dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $2 | ' | ' | ' | ' | ' | ' | ' | $100 | $3 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Preferred Stock, Dividend Rate, Percentage | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 2.50% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Convertible Preferred Stock, Redemption, Period | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '3 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Stock Redeemed or Called During Period, Shares | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 250 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Payments of Ordinary Dividends, Preferred Stock and Preference Stock (in Dollars) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $2,917 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Stock Redeemed or Called During Period, Value (in Dollars) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 27,500 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Dividends, Preferred Stock (in Dollars) | ' | 2,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 2,000 | 2,417 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Dividends Payable (in Dollars) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 6,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Preferred Stock Conversion Rate (in Dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $4 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Conversion Price Reduction Per Share (in Dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $1 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Debt Conversion, Converted Instrument, Warrants or Options Issued | ' | ' | ' | ' | ' | ' | 250,000 | 130,953 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1 | ' | 1,167 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Conversion of Stock, Shares Converted | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 10 | ' | ' | 300 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | ' | ' | ' | ' | ' | ' | $2.50 | $2.50 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $3.10 | ' | ' | ' | ' | $1.12 | $1.68 | $1.71 | $2.50 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $2 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $0.75 | $4.25 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $2.10 | $0.85 | ' | ' |
Convertible Preferred Dividends, Net of Tax (in Dollars) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 5,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Conversion of Stock, Shares Issued | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 11,667 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Stock Conversion Fair Value Per Share For Warrants Issued (in Dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $0.08 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $0.08 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Adjustments to Additional Paid in Capital, Warrant Issued (in Dollars) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 155 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 6,905 | 12,262 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Adjustments to Additional Paid in Capital, Other (in Dollars) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 40,591 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 392,594 | 648,738 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Payments for Commissions (in Dollars) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 116 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs (in Dollars) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 5,746 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Common Stock Voting Rights Votes Per Share | 1 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Treasury Stock, Number of Shares Held | 704,309 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Stock Issued During Period, Shares, Issued for Services | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 124,157 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Share Price (in Dollars per share) | ' | ' | ' | $0.75 | $1.85 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $2.50 | ' | $0.75 | ' | ' | ' | ' | ' | ' | ' | ' | $1.56 | $2.13 | $1.25 | ' | $3.10 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $1.46 | $1.51 | ' | $0.75 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $10 |
Stock Issued During Period, Value, Issued for Services (in Dollars) | 307,102 | 1,269,390 | ' | ' | ' | 307,102 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 148,140 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Common Stock, Capital Shares Reserved for Future Issuance | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 150,000 | 75,000 | 150,000 | 75,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 300,000 | ' | 150,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Allocated Share-based Compensation Expense (in Dollars) | ' | 6,879 | ' | ' | ' | ' | ' | ' | ' | 562,000 | ' | 97,125 | 210,513 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 3,546 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,885,000 | ' | ' | ' | ' | ' | 204,257 | 455,080 | ' | ' | ' | ' | ' | ' | ' | ' | 8,325 | ' | ' | 5,000 | 25,000 | ' | 585,000 | 195,000 | 292,500 | ' | 48,750 | ' | ' | ' | ' | 49,700 | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 100,000 | ' | ' | ' | 25,000 | ' | ' | ' | ' |
Sale of Units Price Per Unit Issued (in Dollars per Item) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 2.25 | 2 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Number of Shares Per Unit | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Number of Warrants Per Unit | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Sale of Units Number of Units Issued | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 177,556 | 330,500 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Proceeds from Issuance or Sale of Equity (in Dollars) | 944,400 | 1,330,499 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 399,499 | 661,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Warrant Fair Value Price Per Share (in Dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $0.08 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Stock Issued During Period, Shares, New Issues | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 40,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 592,534 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 400,000 | 216,000 | ' | ' | 40,000 | ' | 20,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 266,667 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Stock Issued During Period, Value, New Issues (in Dollars) | 967,575 | 292,375 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 30,000 | 25,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 292,375 | ' | ' | ' | 30,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Stock Issued During Period, Shares, Other | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 13,369 | ' | ' | ' | ' | ' | ' | ' | ' | ' | 120,000 | 120,000 | ' | ' | ' | ' | ' | ' | ' |
Stock Issued During Period, Value, Other (in Dollars) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 19,940 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Stock Issued During Period, Shares, Conversion of Convertible Securities | 250,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Stock Issued During Period, Value, Conversion of Units (in Dollars) | ' | ' | ' | ' | ' | ' | 187,500 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Debt Conversion, Original Debt, Amount (in Dollars) | ' | ' | ' | ' | ' | ' | 187,500 | 110,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Debt Instrument, Convertible, Conversion Price (in Dollars per share) | ' | ' | ' | ' | ' | ' | $0.75 | $0.84 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Proceeds from Issuance of Common Stock (in Dollars) | 944,400 | 270,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 467,575 | 474,400 | ' | ' | ' | ' | ' | ' | ' | 500,000 | ' | ' | 500,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Class of Warrant or Right, Outstanding | 7,600,000 | ' | ' | ' | ' | ' | ' | ' | 5,874,528 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 5,419,324 | 35,465 | 38,786 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted Average Exercise Price for Outstanding Warrants (in Dollars per share) | $2.18 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted Average Remaining Contractual Life for Outstanding Warrants | '3 years 9 months | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 165,250 | ' | ' | 88,779 | ' | ' | ' | ' | 35,465 | 68,786 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 25,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 50,000 | ' | 250,000 | ' | ' | ' | ' | ' | 105,000 | ' | ' |
Fair Value per Share for Warrants (in Dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $0.10 | $0.10 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $0.10 | $0.10 | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '5 years | '5 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '10 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Percent Of Exercise Price To Be Offset | 75.00% | 75.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Extension of Expiration Date, Number of Warrants | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 166,500 | ' | ' | ' |
Interest Expense, Other (in Dollars) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 10,500 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Conversion Price Per Unit (in Dollars) | ' | ' | ' | ' | ' | ' | 0.75 | 0.84 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 17,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | 4,258,870 | 5,261,145 | 5,111,145 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 2,295,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | 97,725 | 150,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 97,725 | 150,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 100,000 | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | 200,000 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | 900,000 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value (in Dollars) | 54,022 | 599,650 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options (in Dollars) | $0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Note_8_Stockholders_Equity_Det1
Note 8 - Stockholders' Equity: (Details) - Stock Options - Valuation Assumptions | 12 Months Ended | |
Jun. 30, 2014 | Jun. 30, 2013 | |
Note 8 - Stockholders' Equity: (Details) - Stock Options - Valuation Assumptions [Line Items] | ' | ' |
Volatility | 54.00% | 66.00% |
Dividend yield | 0.00% | ' |
Risk-free interest rate | 0.95% | 0.32% |
Expected term (years) | '3 years 105 days | '3 years 18 days |
Minimum [Member] | ' | ' |
Note 8 - Stockholders' Equity: (Details) - Stock Options - Valuation Assumptions [Line Items] | ' | ' |
Volatility | 49.00% | 60.00% |
Risk-free interest rate | 0.59% | 0.31% |
Expected term (years) | '2 years 229 days | '2 years 240 days |
Maximum [Member] | ' | ' |
Note 8 - Stockholders' Equity: (Details) - Stock Options - Valuation Assumptions [Line Items] | ' | ' |
Volatility | 65.00% | 68.00% |
Risk-free interest rate | 1.69% | 0.34% |
Expected term (years) | '4 years 244 days | '3 years 3 months |
Note_8_Stockholders_Equity_Det2
Note 8 - Stockholders' Equity: (Details) - Stock Options Activity (USD $) | 0 Months Ended | 12 Months Ended | |
Jul. 01, 2012 | Jun. 30, 2014 | Jun. 30, 2013 | |
Stock Options Activity [Abstract] | ' | ' | ' |
Outstanding | 5,111,145 | 5,261,145 | 5,111,145 |
Outstanding | $2.86 | $2.84 | $2.86 |
Outstanding | '4 years 219 days | '3 years 73 days | '4 years |
Exercisable at June 30, 2014 | ' | 4,258,870 | ' |
Exercisable at June 30, 2014 | ' | $2.81 | ' |
Exercisable at June 30, 2014 | ' | '3 years 73 days | ' |
Exercisable at June 30, 2014 | ' | $10,500 | ' |
Granted | ' | 97,725 | 150,000 |
Granted | ' | $1.35 | $2.10 |
Exercised | ' | 0 | 0 |
Exercised | ' | $0 | $0 |
Forfeited | ' | -200,000 | 0 |
Forfeited | ' | $3 | $0 |
Expired | ' | -900,000 | 0 |
Expired | ' | $2.84 | $0 |
Outstanding | ' | 4,258,870 | 5,261,145 |
Outstanding | ' | $2.81 | $2.84 |
Outstanding | '4 years 219 days | '3 years 73 days | '4 years |
Outstanding | ' | $10,500 | ' |
Note_8_Stockholders_Equity_Det3
Note 8 - Stockholders' Equity: (Details) - Nonvested Share Activity (USD $) | 12 Months Ended | |
Jun. 30, 2014 | Jun. 30, 2013 | |
Nonvested Share Activity [Abstract] | ' | ' |
Options | 325,000 | ' |
Weighted Average Grant-Date Fair Value | $1.86 | ' |
Granted | 97,725 | 150,000 |
Granted | $0.58 | ' |
Vested | -222,725 | ' |
Vested | ($1.08) | ' |
Forfeited | -200,000 | ' |
Forfeited | ($2.10) | ' |
Options | 0 | 325,000 |
Weighted Average Grant-Date Fair Value | $0 | $1.86 |
Note_8_Stockholders_Equity_Det4
Note 8 - Stockholders' Equity: (Details) - Allocation of Recognized Period Costs (USD $) | 12 Months Ended | |
Jun. 30, 2014 | Jun. 30, 2013 | |
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ' | ' |
Stock-based employee compensation expense | ' | $6,879 |
General and Administrative Expense [Member] | Stock Bonus [Member] | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ' | ' |
Stock-based employee compensation expense | ' | 1,159,575 |
General and Administrative Expense [Member] | Individual Employee [Member] | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ' | ' |
Stock-based employee compensation expense | 94,998 | 99,996 |
General and Administrative Expense [Member] | Employee Stock Option [Member] | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ' | ' |
Stock-based employee compensation expense | -87,517 | 416,804 |
General and Administrative Expense [Member] | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ' | ' |
Stock-based employee compensation expense | 315,119 | 4,173,075 |
Change in fair value from modification of option terms | 307,638 | 2,496,700 |
Research and Development Expense [Member] | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ' | ' |
Stock-based employee compensation expense | -116,739 | 38,276 |
Employee Stock Option [Member] | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ' | ' |
Stock-based employee compensation expense | $204,257 | $455,080 |
Note_9_Gain_on_Extinguishment_1
Note 9 - Gain on Extinguishment of Liabilities: (Details) (USD $) | 12 Months Ended |
Jun. 30, 2014 | |
Gain On Extinguishment Of Liabilities [Text Block] [Abstract] | ' |
Gains (Losses) on Extinguishment of Debt | $20,113 |
Note_10_Operating_Lease_Detail
Note 10 - Operating Lease: (Details) (USD $) | 1 Months Ended | |
Oct. 31, 2013 | Jan. 01, 2009 | |
Secured Debt [Member] | ||
Note 10 - Operating Lease: (Details) [Line Items] | ' | ' |
Restricted Cash and Cash Equivalents | ' | $57,315 |
Increase (Decrease) in Restricted Cash | ($57,315) | ' |
Note_11_Income_Taxes_Details
Note 11 - Income Taxes: (Details) (USD $) | 12 Months Ended |
Jun. 30, 2014 | |
Income Tax Disclosure [Abstract] | ' |
Operating Loss Carryforwards | $48,401,000 |
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | 100.00% |
Note_11_Income_Taxes_Details_R
Note 11 - Income Taxes: (Details) - Reconciliation Schedule of Federal Income Tax Benefits (USD $) | 12 Months Ended | |
Jun. 30, 2014 | Jun. 30, 2013 | |
Reconciliation Schedule of Federal Income Tax Benefits [Abstract] | ' | ' |
Expected income tax benefit at statutory rate | ($1,959,000) | ($2,805,000) |
State taxes, net of federal benefit | -177,000 | -252,000 |
Permanent differences and other | -19,000 | -28,000 |
Expiration of NOLs | 0 | 0 |
Change in valuation allowance | 2,155,000 | 3,085,000 |
Income tax benefit | $0 | $0 |
Note_11_Income_Taxes_Details_T
Note 11 - Income Taxes: (Details) - Table of Estimated Deferred Tax Assets and Liabilities (USD $) | Jun. 30, 2014 | Jun. 30, 2013 |
Table of Estimated Deferred Tax Assets and Liabilities [Abstract] | ' | ' |
NOLs - noncurrent | $18,392,000 | $17,479,000 |
Stock-based compensation - current | 4,832,000 | 4,684,000 |
Property and equipment - noncurrent | 741,000 | ' |
Deferred compensation - noncurrent | 1,036,000 | 683,000 |
25,001,000 | 22,846,000 | |
Valuation allowance | -25,001,000 | -22,846,000 |
Net deferred tax assets | $0 | $0 |
Note_12_401k_Plan_Details
Note 12 - 401(k) Plan: (Details) | 12 Months Ended |
Jun. 30, 2014 | |
Compensation and Retirement Disclosure [Abstract] | ' |
Defined Contribution Pension And Other Postretirement Plans Minimum Age | '21 years |
Note_13_Commitments_And_Contin1
Note 13 - Commitments And Contingencies: (Details) (USD $) | 12 Months Ended | 82 Months Ended | 12 Months Ended | 2 Months Ended | 12 Months Ended | 6 Months Ended | 12 Months Ended | 36 Months Ended | 36 Months Ended | 2 Months Ended | 12 Months Ended | 8 Months Ended | 12 Months Ended | 18 Months Ended | 4 Months Ended | 12 Months Ended | 23 Months Ended | 12 Months Ended | 36 Months Ended | 23 Months Ended | 36 Months Ended | 82 Months Ended | 12 Months Ended | 5 Months Ended | 29 Months Ended | 26 Months Ended | |||||||||||||||||||||||||||||||||||||||||||
Jun. 30, 2014 | Jun. 30, 2013 | Jul. 31, 2013 | Jun. 30, 2014 | Jun. 30, 2014 | Jun. 30, 2014 | Jun. 30, 2014 | Jun. 30, 2012 | Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2014 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Sep. 23, 2014 | Sep. 23, 2014 | Jun. 30, 2013 | Jul. 15, 2012 | Jan. 01, 2011 | Jun. 30, 2014 | Jul. 15, 2012 | Dec. 31, 2012 | Jun. 30, 2014 | 31-May-05 | Jan. 01, 2012 | Dec. 31, 2012 | Jun. 30, 2014 | 31-May-05 | Jan. 01, 2012 | Jun. 30, 2012 | Jun. 30, 2013 | Jun. 30, 2013 | Jun. 30, 2012 | Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2012 | Jun. 30, 2013 | Jun. 30, 2013 | Jun. 30, 2012 | Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2012 | Dec. 31, 2013 | Jun. 30, 2014 | Jun. 30, 2014 | Jun. 30, 2014 | Jun. 30, 2014 | Jun. 30, 2014 | Jun. 30, 2012 | Aug. 31, 2012 | Jun. 30, 2012 | Jun. 30, 2013 | Feb. 28, 2014 | Jun. 30, 2014 | Jun. 30, 2013 | Jul. 14, 2012 | Jun. 30, 2012 | Jun. 30, 2013 | Jun. 30, 2014 | Jun. 30, 2013 | Sep. 30, 2012 | Jun. 30, 2014 | Dec. 31, 2013 | Jun. 30, 2013 | Jul. 31, 2013 | Dec. 31, 2012 | Jun. 30, 2011 | Nov. 30, 2013 | Nov. 30, 2013 | |
CEO and President [Member] | CEO and President [Member] | Employment Termination Severance Pay [Member] | Accrued Employment Obligations [Member] | Stock Bonus [Member] | Exercise Bonus [Member] | Exercise Bonus [Member] | Exercise Bonus [Member] | Cash Compensation [Member] | Cash Compensation [Member] | Common Stock Payable [Member] | Subsequent Event [Member] | Subsequent Event [Member] | Stock Bonus Payable Upon Stock Price of $10.00 per Share [Member] | Stock Bonus Payable Upon Stock Price of $10.00 per Share [Member] | Stock Bonus Payable Upon Stock Price of $10.00 per Share [Member] | Stock Bonus Payable Upon Stock Price of $10.00 per Share [Member] | Stock Bonus Payable Upon Stock Price of $10.00 per Share [Member] | Stock Bonus Payable Upon Stock Price of $10.00 per Share [Member] | Stock Bonus Payable Upon Stock Price of $10.00 per Share [Member] | Stock Bonus Payable Upon Stock Price of $10.00 per Share [Member] | Stock Bonus Payable Upon Stock Price of $10.00 per Share [Member] | Stock Bonus Payable Upon Stock Price of $20.00 per Share [Member] | Stock Bonus Payable Upon Stock Price of $20.00 per Share [Member] | Stock Bonus Payable Upon Stock Price of $20.00 per Share [Member] | Stock Bonus Payable Upon Stock Price of $20.00 per Share [Member] | Tranch 1 [Member] | Tranch 1 [Member] | Tranch 1 [Member] | Tranch 1 [Member] | Tranch 1 [Member] | Tranch 1 [Member] | Tranch 2 [Member] | Tranch 2 [Member] | Tranch 2 [Member] | Tranch 2 [Member] | Tranch 2 [Member] | Tranch 2 [Member] | Tranch 3 [Member] | Upon Company Has Completed an Equity Financing in Excess of $3,000,000 [Member] | Termination of Officer [Member] | Termination of Officer [Member] | Morris Versus Bion [Member] | Morris Versus Bion [Member] | Morris Versus Bion [Member] | Initial Amounts [Member] | President [Member] | President [Member] | President [Member] | President [Member] | President [Member] | President [Member] | Chief Executive Officer [Member] | Chief Executive Officer [Member] | Chief Executive Officer [Member] | Chief Executive Officer [Member] | Chief Executive Officer [Member] | Chief Executive Officer [Member] | Executive Vice Chairman [Member] | Executive Vice Chairman [Member] | Executive Vice Chairman [Member] | Chief Operating Officer [Member] | Vice President [Member] | Chief Technology Officer [Member] | Chief Technology Officer [Member] | Chief Engineering Officer [Member] | ||||
Exercise Bonus [Member] | Minimum [Member] | Morris Versus Bion [Member] | Morris Versus Bion [Member] | Chief Executive Officer [Member] | Maximum [Member] | CEO and President [Member] | CEO and President [Member] | Upon Company Has Completed an Equity Financing in Excess of $3,000,000 [Member] | Executive Vice Chairman [Member] | Executive Vice Chairman [Member] | Deferral of Extension 1 Tranch 1 [Member] | Deferral of Extension 2 Tranch 1 [Member] | President [Member] | President [Member] | President [Member] | Executive Vice Chairman [Member] | Executive Vice Chairman [Member] | Vice President [Member] | Key Employees [Member] | Key Employees [Member] | Vice President [Member] | Consultants [Member] | Consultants [Member] | President [Member] | President [Member] | President [Member] | Chief Executive Officer [Member] | Chief Executive Officer [Member] | Chief Executive Officer [Member] | President [Member] | President [Member] | President [Member] | Chief Executive Officer [Member] | Chief Executive Officer [Member] | Chief Executive Officer [Member] | Chief Executive Officer [Member] | Executive Vice Chairman [Member] | Chief Technology Officer [Member] | Chief Engineering Officer [Member] | Minimum [Member] | Maximum [Member] | President [Member] | Extension Agreement One [Member] | Extension Agreement One [Member] | Extension Agreement 2 [Member] | Extension Agreement 2 [Member] | Extension Agreement One [Member] | Extension Agreement One [Member] | Extension Agreement 2 [Member] | Extension Agreement 2 [Member] | |||||||||||||||||||
Extension Agreement One [Member] | CEO and President [Member] | Executive Vice Chairman [Member] | Chief Executive Officer [Member] | Chief Executive Officer [Member] | Extension Agreement 2 [Member] | Extension Agreement One [Member] | Extension Agreement 2 [Member] | Extension Agreement One [Member] | Extension Agreement 2 [Member] | Extension Agreement One [Member] | Extension Agreement 2 [Member] | Extension Agreement One [Member] | Extension Agreement 2 [Member] | Extension Agreement One [Member] | Extension Agreement One [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Extension Agreement Three [Member] | Extension Agreement Three [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Note 13 - Commitments And Contingencies: (Details) [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Monthly Officers' Compensation (in Dollars) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $20,000 | ' | ' | $21,000 | $14,000 | ' | $26,000 | ' | ' | $26,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Common Stock, Capital Shares Reserved for Future Issuance | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 100,000 | 150,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 45,000 | 75,000 | 75,000 | 100,000 | 150,000 | 150,000 | 45,000 | 75,000 | 75,000 | 100,000 | 150,000 | 150,000 | 100,000 | ' | ' | ' | ' | ' | ' | ' | ' | 90,000 | 150,000 | ' | ' | 150,000 | ' | 300,000 | ' | 300,000 | 300,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Allocated Share-based Compensation Expense (in Dollars) | ' | 6,879 | ' | ' | ' | ' | ' | 795,000 | ' | 1,885,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 240,300 | ' | 334,000 | 292,500 | ' | ' | 292,500 | ' | 1,203,500 | 585,000 | ' | 585,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | 97,725 | 150,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 200,000 | ' | ' | ' | ' | ' | 725,000 | ' | ' | ' | ' | 100,000 | ' | ' | ' | 75,000 | ' | ' | ' |
Deferred Compensation Arrangement with Individual, Exercise Price (in Dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $3 | $2.10 | ' | ' | ' | ' | $3 | $2.10 | ' | ' | ' | $2.10 | ' | ' | ' | $2.75 | ' | ' | ' |
Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants (in Dollars) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 25,000 | ' | ' | ' | ' | ' | 5,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Stock Issued During Period, Shares, Conversion of Units | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 250,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 100,000 | 100,000 | 50,000 | 25,000 | 25,000 | 12,500 | 227,500 | ' | 12,500 | ' | 65,000 | ' | 12,500 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 100,000 | ' | ' | ' | ' | ' | ' | ' | ' | 25,000 | ' | ' | ' | ' | ' |
Share Price (in Dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $10 | ' | ' | $10 | ' | $10 | ' | $10 | ' | $20 | ' | $20 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
undefined (in Dollars) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 225,000 | 150,000 | 100,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 312,000 | ' | 250,000 | ' | 150,000 | 144,000 | 150,000 | 180,000 | 180,000 |
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 250,000 | ' | ' | 50,000 | ' | 50,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Unused Vacation Time | ' | ' | ' | ' | '10 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Execution Bonus as a Percentage of Exercised Options and Warrants | ' | ' | ' | 50.00% | ' | ' | ' | ' | ' | ' | 50.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Employment Agreement, Term | ' | ' | '4 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '3 years | ' | ' | ' | ' | ' | ' |
Percentage of Full-Time Employment | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 75.00% | ' | ' | ' | ' | ' | ' |
Equity Financing, Requirement for Compensation Increase (in Dollars) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 3,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Accrued Liabilities, Current (in Dollars) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 75,000 | 75,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Deferred Compensation Liability, Current and Noncurrent (in Dollars) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 186,000 | 120,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Contingent Stock Bonus, Percentage Threshold for Issuance | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 50.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Extension of Exercise Period | ' | ' | ' | ' | ' | ' | ' | ' | '5 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Loss Contingency, Damages Sought, Value (in Dollars) | ' | ' | ' | ' | ' | $90,000 | $87,216 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Loss Contingency Damages Sought, Options | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 300,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Litigation Share Price (in Dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $2 | $3 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Note_14_Subsequent_Events_Deta
Note 14 - Subsequent Events: (Details) (USD $) | 12 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | ||||
Jun. 30, 2014 | Jun. 30, 2013 | Sep. 23, 2014 | Jun. 30, 2014 | Sep. 23, 2014 | Sep. 23, 2014 | Sep. 23, 2014 | Sep. 23, 2014 | |
Employees and Consultants [Member] | Employees and Consultants [Member] | Subsequent Event [Member] | Subsequent Event [Member] | Subsequent Event [Member] | Subsequent Event [Member] | |||
Subsequent Event [Member] | Subscription Agreement [Member] | Employees and Consultants [Member] | Restricted Common Stock [Member] | |||||
Restricted Common Stock [Member] | ||||||||
Note 14 - Subsequent Events: (Details) [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' |
Stock Issued During Period, Shares, Issued for Services | ' | ' | ' | ' | ' | 4,496 | ' | ' |
Stock Issued During Period, Value, Issued for Services | $307,102 | $1,269,390 | $4,600 | $307,102 | ' | ' | ' | ' |
Stock Issued During Period, Shares, New Issues | ' | ' | ' | ' | 40,000 | ' | 35,000 | ' |
Stock Issued During Period, Value, New Issues | 967,575 | 292,375 | ' | ' | 30,000 | ' | ' | ' |
Stock Issued During Period, Price Per Share | ' | ' | ' | ' | ' | ' | $0.75 | ' |
Proceeds from Issuance of Common Stock | 944,400 | 270,000 | ' | ' | ' | ' | 26,250 | ' |
Debt Conversion, Converted Instrument, Units Issued | ' | ' | ' | ' | ' | ' | ' | 130,953 |
Number of Shares Per Unit | ' | ' | ' | ' | ' | ' | ' | 1 |
Number of Warrants Per Unit | ' | ' | ' | ' | ' | ' | ' | 1 |
Debt Conversion, Original Debt, Amount | ' | ' | ' | ' | ' | ' | ' | $110,000 |
Debt Instrument, Convertible, Conversion Price | ' | ' | ' | ' | ' | ' | ' | $0.84 |